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Kurzfassung 
Neuroblastoma ist die häufigste Art von extracranialen, soliden Tumoren bei Kindern. Häufig treten 
Amplifikationen des MYCN Gens auf, die im Zellkern als double minute chromosomes oder als 
homogenous staining region vorliegen. 
Durch Behandlung mit niedrigen Dosen von Hydroxyurea (HU) können die amplifizierten MYCN 
Genkopien selektiv aus dem Zellkern geschleust werden und in Mikrokernen nachgewiesen werden. 
Außerdem wurde in den malignen Neuroblastomzellen nach einer sechswöchigen niedrig dosierten 
Behandlung mit HU zelluläre Seneszenz nachgewiesen. In gutartigen humanen Zellen wird diese 
zelluläre Veränderung durch irreversiblen Proliferationsstillstand gekennzeichnet, was durch cyclin 
dependent kinases inhibitors (CDKI) und Aktivierung von p53 und pRb bedingt wird. Weiters wird 
Seneszenz durch erhöhte mitochondriale Radikalfreisetzung und Änderung der Komponenten der 
Kernmatrix- und -membran gekennzeichnet. 
Das Ziel dieser Diplomarbeit war es Kandidaten-Signalwege zu erforschen, die im Prozess der 
Hydroxyurea induzierten Seneszenzentstehung in MYCN amplifizierten Neuroblastomazellen 
wichtig sind. 
Dafür wurden zeitliche Veränderungen des Zellzyklus, des zellulären Sauerstoffradikalgehalts und 
der mitochondrialen Begebenheiten wie Membranpotential und Masse während der HU Behandlung 
mittels Durchflußzytometrie ermittelt. Mit Immunfluoreszenz-Mikroskopie wurden zusätzlich die 
Kernmorphologie und Komponenten der nukleären Matrix ermittelt. Proteinanalysen der CDKIs 
sowie von assoziierten Proteinen und von MYCN erfolgten mittels Western Blot. 
Wesentliche Resultate zeigten, dass nach 3-5 Tagen HU Behandlung die Zellen in der S-Phase des 
Zellzyklus akkumulierten. Im gleichen Zeitfenster wurde p16 reduziert und p53 erhöht 
nachgewiesen. Von Tag 10 an wurde eine Reduktion des MYCN- und pRb-Proteinlevels 
nachgewiesen und die Anzahl der Zellen die sich in G1-Phase befanden erhöhte sich. Zusätzlich 
stieg der p21 Proteingehalt an und p16 erhöhte sich wieder. 
Während der achtwöchigen Behandlung akkumulierten stetig Sauerstoffradikale zu einem 13-
fachen Anstieg. Auch die Mitochondrien erreichten eine 3.4-fache Masse und hatten ein zur Hälfte 
reduziertes Membranpotential. Zuvor fehlendes Lamin A/C wurde in 67% der 8 Wochen 
behandelten Zellen gefunden und die Kernhülle dieser Zellen war verformt und lobuliert.  
In HU behandelten MNA-NB Zellen könnte Seneszenz durch Akkumulation von oxidativem Stress, 
durch p21-p53 Induktion, durch Aufhebung der MYCN Expression und durch Änderung der 
Kernstruktur entstehen. 
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Abstract 
Neuroblastoma (NB) is the most common extra-cranial solid childhood tumour, frequently 
associated with MYCN amplification (MNA). Selective expulsion of double-minute chromosomes, 
carrying the amplified gene can be induced by low dose hydroxyurea (HU) treatment. Moreover, 
chronic low-dose HU induces senescence after six weeks in malignant neuroblastoma cells. In 
benign human cells, key pathways of senescence-associated irreversible proliferation arrest involve 
cyclin dependent kinases inhibitors (CDKI) and activation of p53 and pRb. In addition, cellular 
changes in senescent cells include increased mitochondrial radical levels and alterations of 
components of the nuclear lamina. 
The aim of this study was to investigate candidate pathways involved in HU-induced senescence of 
MNA NB cells.  
Thus, time dependent changes of cell cycle, reactive oxygen species (ROS), mitochondrial mass and 
membrane potential ∆ψm were assessed by flow cytometry. Furthermore, nuclear morphology and 
lamina composition was monitored by immune fluorescence microscopy. Expression of CDKIs and 
associated proteins was determined by western blotting together with MYCN. 
We found that cells accumulated in S-phase 1 – 5 days after treatment accompanied by decrease in 
p16 and increase in p53 expression. From day 10 onwards a descent in MYCN and pRb was found 
and the proportion of cells in the G1-phase increased. Additionally, p21 rose and p16 recovered. 
ROS levels accumulated steadily to13-fold after 8 weeks and mitochondria were increased 3.4-fold 
in mass with 50% decrease in mitochondrial membrane potential. Previously lacking lamin A/C was 
expressed in 67% and the nuclear envelope was lobular in senescent cells after 8 weeks HU-
treatment. 
In MNA NB cells, senescence may be induced by accumulating oxidative stress leading to p53-p21 
induction, abrogation of MYCN expression and finally changes in nuclear structure.
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1 Introduction 
Tumour cells acquire their transforming behaviour by accumulating mutations and/or changing 
regulation patterns that would normally keep the cells under high suppression and control. 
Mechanisms like evasion of apoptosis, independency on intra- and extra-cellular stimuli, change in 
functionality comprising angiogenesis, tissue invasion, increased proliferative capacity and limitless 
replicative potential lead to a selective advantage of these cells (Figure 1) (Hanahan and Weinberg 
2000). 
 
Figure 1 Acquired Capabilities of Cancer. (Hanahan and Weinberg 2000) 
1.1 Neuroblastoma  
1.1.1 General features 
Neuroblastoma is the most common solid extra cranial childhood tumour. It is an embryonic 
neoplasm of the postganglionic sympathetic nervous system. The frequency of detection in children 
with less than 15 years of age is rated 1 in 100000 (Ladenstein, Berthold et al. 2006), with an 
average age of diagnosis of 18 month. The real number of incidences may be much higher due to a 
high frequency of spontaneous regression as indicated by mass screening programs in Japan, 
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Canada, and Europe (Brodeur 2003; Ladenstein, Berthold et al. 2006).  
The clinical hallmark of this neoplasm is heterogeneity. Some tumours may undergo spontaneous 
regression or maturation/differentiation to a benign neoplasm. Others exhibit an extremely 
malignant phenotype with regional or disseminated disease which frequently is resistant to intensive 
therapy (Brodeur 2003). Conflicting opinions exist about the multitude of genetic aberrations, 
interactions and their usage as prognostic markers. These range from 1p loss of heterogeneity 
(Caron 1995), allelic loss of the long arm of chromosome 11 (White, Maris et al. 1997), 14q 
deletions (Thompson, Seifried et al. 2001) to MYCN amplification. Moreover, to date only one 
hereditary neuroblastoma predisposition gene (HNB1) has been found which was linked to locus 
16p12-13 and was suggested to be PHOX2B (Weiss, Guo et al. 2000; Bourdeaut, Trochet et al. 
2005). 
Next to genetic aberrations, gene expression changes have been observed in neuroblastomas. 
Signals important for the development of the sympathetic nervous system like the neurotrophins are 
deregulated in neuroblastoma. TrkA downregulation as well as TrkB upregulation is related to 
MYCN amplification, aggressive tumour behaviour and unfavourable outcome (Nakagawara, Arima 
et al. 1992; Suzuki, Bogenmann et al. 1993; Nakagawara, Azar et al. 1994). Moreover, drug 
resistance progressively increases with therapy in neuroblastomas by induction of MDR1 and 
ABCC1 (Keshelava, Seeger et al. 1997). 
Spontaneous regression of neuroblastoma may be related to delayed onset of apoptotic pathways 
(Oue, Fukuzawa et al. 1996). Bcl-2 is supposed to contribute to survival of cells in neurogenesis by 
inhibiting apoptosis and is, in neuroblastoma, strongly correlated with MYCN amplification and 
aggressive tumour behaviour (Castle, Heidelberger et al. 1993). Another important fact is that 94% 
of all neuroblastomas revealed telomerase expression. High activity was related to MYCN 
amplification and to poor prognosis, while low telomerase activity was associated with good 
prognosis (Hiyama, Hiyama et al. 1995). 
1.1.2 MYCN 
1.1.2.1 MYCN Amplification (MNA) 
MYCN was identified as amplified genetic region in neuroblastoma cell lines as well as in a primary 
tumour, with partial homology to the MYC proto-oncogene (Kohl, Kanda et al. 1983; Schwab, 
Alitalo et al. 1983). MYCN is situated on the short arm of chromosome 2 (2p24) from where it is 
amplified as extrachromosomal double minute chromosomes (dmin) that may be linearized and 
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further integrate randomly into the genome to form homogenously staining regions (hsr)(Kohl, 
Kanda et al. 1983). One MYCN copy is retained at its original locus on chromosome 2 (Seeger, 
Brodeur et al. 1985; Corvi, Amler et al. 1994). Amplified MYCN copies are associated with rapid 
progression of disease in untreated neuroblastomas (Brodeur, Seeger et al. 1985; Seeger, Brodeur et 
al. 1985). 70 percent of patients whose tumour comprised only one MYCN copy had progression-
free survival eighteen month after diagnosis, whereas 95 percent of patients with 10 and more 
copies per diploid genome displayed advanced disease (Corvi, Amler et al. 1994). MNA is detected 
in about 30 percent of untreated neuroblastomas and suggests an intrinsic biologic property that is 
found in a subset of neuroblastomas already at time of diagnosis, demonstrating a powerful 
predictor of poor prognosis (Brodeur, Hayes et al. 1987).  
1.1.2.2 MYCN Expression and Function 
Expression of MYCN proto-oncogene is normally restricted to the nervous system and selected 
other tissues of the developing embryo. The 49,6 kD oncoprotein (Wu, Apweiler et al. 2008) is a 
member of the superfamily of transcription factors (Slamon, Boone et al. 1986). Like other 
members of the MYC family, MYCN contains a basic DNA binding region (BR), a helix-loop-helix 
(HLH) and a leucine zipper motif at the carboxy-terminus and an amino-terminal transactivation 
domain (MYC box) (Wenzel, Cziepluch et al. 1991). This nuclear protein has a short half-life and 
acts as a transcription factor only in heterodimerized form. MAX, another ubiquitously expressed 
nuclear protein with basic helix-loop-helix/leucine zipper motif (bHLH-LZ) and long half-life is its 
binding partner. MYCN and MAX heterodimerize via their bHLH-LZ motifs to form a complex 
that can bind to the DNA sequence CACGTG (Wenzel and Schwab 1995), also called E-Box. The 
MYC/MAX complex acts as transcriptional activator and is suggested to influence cell growth and 
proliferation through direct activation of genes involved in DNA synthesis, RNA metabolism and 
cell-cycle progression (Grandori and Eisenman 1997). In contrast, the homodimerized MAX-
complex as well as heterodimers formed with nuclear proteins MAD and MXI1 are transcriptional 
repressive. Moreover, these two members of the MYC-related bHLH-LZ family of proteins 
compete with MYCN to form a complex with MAX (Lahoz, Xu et al. 1994; Foley and Eisenman 
1999). 
MYCN exerts its oncogenic effects through transcriptional upregulation of numerous target genes 
including ABCC1 (Norris, Bordow et al. 1997), MCM7 (Shohet, Hicks et al. 2002), the p53 
inhibitor MDM2 (Slack and Shohet 2005), HMGA1 (Giannini, Cerignoli et al. 2005) and repression 
of DKK genes (Koppen, Ait-Aissa et al. 2007; Koppen, Ait-Aissa et al. 2008). 
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1.1.2.3 Prognostic Implications of MYCN 
Commonly, MYCN amplification correlates with high levels of MYCN protein and aggressive 
tumour behaviour (Nakagawara, Arima et al. 1992) but also non-MYCN-amplified cell lines can 
express high levels of MYCN. In these cells alternations in the protein degradation pathway might 
lead to a long half-life of MYCN proteins (Cohn, Salwen et al. 1990). 
High-resolution restriction mapping of the MYCN locus suggests that a 130kb core domain is 
amplified, containing no other expressed gene constantly amplified in human neuroblastomas 
(Reiter and Brodeur 1996; Reiter and Brodeur 1998). Still, DDX1 and NAG were found co-
amplified repeatedly with MYCN in cell lines and primary tumours (George, Kenyon et al. 1996; 
Wimmer, Zhu et al. 1999). Moreover, increased expression of genes in the vicinity of MYCN, like 
ALK, were demonstrated (Stock, Bozsaky et al. 2008). 
1.1.2.4 Nuclear Organization and Expulsion of Amplified Genetic Material 
Like in many cancer cells, also in neuroblastoma amplified genes are present as dmin or hsr 
(Benner, Wahl et al. 1991). Dmin are minichromosomal genetic elements with circular, few 
megabase sized DNA. They lack functional centromeres and telomeres, and frequently dmin are 
autonomously replicating. Dmin are found to localize to peripheral nuclear sites after nuclear 
membrane breakdown. Further localisation during the cell cycle was revealed in Table 1. Studies 
analysing primary MNA neuroblastomas conclude that more than 90% of the amplified DNA is 
present as dmin (Benner, Wahl et al. 1991; Moreau, McGrady et al. 2006). 
 
Cell cycle phase location and nature of dmin 
S-phase relocated to the centre or expelled by budding, 
colocalization with lamins 
G2 dmin are uncoupled 
Anaphase lag behind 
Prometaphase locate near the chromosome rosettes at the 
periphery 
Table 1 Location and nature of dmin chromosomes during the cell cycle (Deng, Zhang et al. 2006). 
It has been concluded that dmin, chromosome fragments and lagging genetic material can give rise 
to micronuclei (Schiffmann and De Boni 1991). Micronuclei are intracellular compartments 
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surrounded by a nuclear membrane and localize near the nucleus.  
There are at least two different pathways explaining how dmin are incorporated into micronuclei. 
The classical pathway describes lagging acentric chromosomes that are enclosed into nuclear 
membranes after mitosis, when the nuclear membrane forms again (Ford, Schultz et al. 1988). The 
other mechanism was found to take place during S-phase selectively, when dmin are situated to the 
periphery of the nucleus (Tanaka and Shimizu 2000). These spatially defined dmin have been 
shown to associate with lamins during S-phase (Itoh and Shimizu 1998; Tanaka and Shimizu 2000). 
These associated complexes of dmin and lamins form extrusions often referred to as nuclear buds 
that evolve into micronuclei that are rich in dmin genetic material during metaphase/anaphase 
transition (Shimizu, Itoh et al. 1998). 
Micronuclei are inducible by many different mutagens including clastogens - substances that cause 
breakage of chromosomes - and aneugens – substances that affect cell division and the mitotic 
spindle apparatus. Additionally, also ionizing radiation induces micronuclei by means of double 
strand breaks (DSB) (Schoenlein, Barrett et al. 2003). Prolonged cell cycle duration, higher 
incidence of double strand breaks and a reduced DNA repair are typical incidences in premature 
and physiological aging. Cells from patients with premature aging syndromes and from aged, 
healthy controls show an elevated formation of micronuclei (Weirich-Schwaiger, Weirich et al. 
1994). 
The mechanism and function of selective expulsion of extrachromosomal material is still not clear. 
Moreover, the effects micronuclei exert in the cytoplasm and whether they are degraded or expulsed 
from the cell are to be explored. 
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1.2 Cellular Senescence 
Somatic cells face different stresses during their lifespan. Dependent on the species, tissue and cell 
type diverse counter mechanisms have evolved that let the organism cope with cellular stress. One 
option is apoptosis with the intention of eliminating stress-damaged cells actively. Another possible 
outcome is differentiation to change the cellular function as means of adaption. Alternatively, 
stressed cells may enter senescence which introduces a permanent proliferation arrest. An example 
for such differences are damaged epithelial cells and fibroblasts which have been shown to senesce, 
while damaged lymphoblasts activate the apoptotic pathway (Campisi and d'Adda di Fagagna 
2007). The predictions of why a cell gets committed for either counter mechanism are still to be 
clarified.  
More than 45 years ago Hayflick first coined the term replicative cellular senescence and referred to 
it as a programmed intracellular event. He showed that normal human cells (embryonic fibroblasts) 
have a limited proliferative capacity in culture. In his in vitro experiments he observed a change in 
phenotype of the fibroblast cell culture: These cells had a segregation blockage but remained alive 
for a prolonged period of time before dying (Hayflick and Moorhead 1961; Hayflick 1965). 
From then on research in this field emerged. Gerontology focused on many theories about the 
coherence of cellular and organismal aging, as well as on theories explaining the onset of 
senescence. The theories established try to explain the molecular, genetic and biologic changes 
observed along with upcoming senescence but still no concordance in ideas could be brought about. 
The major problem reflecting this topic is the extreme heterogeneity between different cell types, 
species and inducers of senescence (Figure 2) which leave possible explanations high. Still, in the 
following chapter accredited general features, markers, the main theories of senescence and the 
pathways leading to its onset are resumed. 
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Figure 2 Inducers of senescence. Multiple types of stresses can induce cells to undergo senescence. The 
combined levels of stress determine how rapidly the entry into senescence will occur (Ben-Porath and 
Weinberg 2005). 
1.2.1 General Features of Senescence and their Approval 
With ongoing senescence, cells undergo several changes listed in Table 2. Whether these changes in 
morphology, expression and metabolism induce senescence or whether this is just the consequence 
of the senescent phenotype still remains unknown. 
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Feature 
irreversible replication blockage 
morphology remodelling 
increased cell volume 
increased granularity 
loss of original shape 
increased adherence 
cell-cell contact inhibition 
change in gene expression 
metabolism change 
prolonged viability 
chromatin silencing 
senescent-associated heterochromatic foci (SAHF) 
shortened telomeres 
increased ROS 
dysfunctional mitochondria 
Table 2 Features of senescence. Summarized from (Goldstein 1990; Dimri, Lee et al. 1995; Toussaint, 
Medrano et al. 2000; Ben-Porath and Weinberg 2004; Ben-Porath and Weinberg 2005; Campisi and d'Adda 
di Fagagna 2007; Itahana, Campisi et al. 2007; Zhang 2007). 
1.2.2 Theories of Senescence 
In this chapter only the main theories of senescence are described. A high convergence in between 
theories is often found, which makes it even harder to differentiate between either of them. Just to 
mention, there are - next to replicative senescence, stress induced premature senescence, like 
oncogene induced and free radical induced aging - theories dealing with the accumulation of 
damage (Kirkwood 2005), accumulation of waste and mitochondrial theory of aging . Replicative 
senescence, was found to result in an DNA damage response (DDR). Also free radicals and 
accumulated damage, elucidate a DDR, which is a connecting part in nearly all theories. (Guo, 
Deng et al. 2007; Passos, Saretzki et al. 2007; Deng, Chan et al. 2008)  
Thus, all theories of senescence simplify this complex cellular network but are probably giving an 
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incomplete description of cellular senescence. Of course for every theory there are experimental 
back up but perhaps not reliable in other systems. Thus, an overlap of all theories depending on the 
species, cell type and senescence inducers may explain the senescence phenomenon more 
adequately. 
1.2.2.1 Replicative Senescence – Role of Telomeres 
Telomeres are heterochromatic, nucleoprotein like structures at the chromosome ends (de Lange 
2005). The function of telomeres is capping and protecting chromosomes from being recognized as 
double strand breaks (DSB), from fusion of chromosome ends and to provide stability to 
chromosomes. 
Replication shortens the telomeric repeats up to 50-100 basepairs each S-phase (Alberts Bruce 
2002). Moreover, oxidative stress leads to telomere uncapping and erosion (Passos and von 
Zglinicki 2005; Passos, Saretzki et al. 2007; Passos, Saretzki et al. 2007). Telomerase, an enzyme 
containing an RNA template for telomeric repeats is able to extend the telomere length. Like this, 
the proliferative capacity of a cell is increased. Tumour cells highjack this mechanism often in order 
to prevent proliferation arrest. Short or uncapped telomeres lead to a situation that resembles 
damaged DNA at the end of linear chromosomes: Chromatin ends are not looped and a free double 
strand is exposed to the surrounding which immediately induces a DNA repair mechanism leading 
to apoptosis or senescence (Deng, Chan et al. 2008). 
1.2.2.2 Stress-Induced-Premature Senescence 
In cells which still have long, capped and protected telomeres senescent features can be induced 
prematurely. This type of senescence is referred to as stress-induced premature senescence (SIPS), 
evolves usually much faster than replicative senescence and many subtypes belong to it. SIPS varies 
dependent on the type of endo- and exogenous stimuli that commit the cells to the senescence 
pathway and often these stresses are cumulative. Oxidative stress, ultra violet radiation (UV), 
ionizing radiation (IR) and chemotherapeutic agents change the point of time and approach to 
undergo senescence when a critical level of stress is acquired. Source and severity of subcytotoxic 
doses of the stressor, the cell type and species influence the molecular mechanisms underlying the 
decision between cell death, differentiation or senescence. In the following chapter the main stimuli 
that induce SIPS are explained and different schemes will be presented. The function of stress 
induced premature senescence seems to be a halt of further proliferation.  Thereby stress induced 
damage cannot segregate to daughter cells. This is thus seen as a parallel mechanism to apoptosis or 
 
 
 
 
 
 
 
20 
differentiation. Like in replicative senescence, a DDR triggers further responses related to 
senescence. (Ben-Porath and Weinberg 2005; von Zglinicki, Saretzki et al. 2005; Campisi and 
d'Adda di Fagagna 2007; Suzuki and Boothman 2008) 
1.2.2.3 Oncogene Induced Senescence (OIS) 
One of the key steps in cellular transformation of cells is immortalization which is done by 
expression of telomerase or by alternative lengthening of telomeres (ALT). Further hallmarks are 
the dominant gain of function of oncogenes and/or recessive loss of function of tumor suppressor 
genes which lead to a deregulation of proliferation and apoptosis. (Hanahan and Weinberg 2000; 
Campisi 2005; Zhang 2007) 
Serrano et al found that oncogenic RAS induces a G1 arrest in primary human and rodent cells 
(Serrano, Lin et al. 1997). From then on many other oncogenes, which are summarized in Table 3, 
were found to induce senescence when upregulated. These include components of the RAS pathway 
and lead to an increased proliferation by growth factor signaling. Overexpression of E2F 
transcription factors also induces premature senescence as cell cycle proceeds unregulated. 
Activation and overexpression of downstream targets of the TGF-β pathway like SMAD3 or 
SMURF2 lead to a senescent phenotype (Funayama and Ishikawa 2007). These in vitro and in vivo 
studies lead to the suggestion that senescence is a cell-intrinsic mechanism suppressing the 
transformation of a benign lesion to a highly proliferative tumor. (Campisi 2005; Di Micco, 
Fumagalli et al. 2007; Zhang 2007)  
It is thought that the level of oncogene expression, at least for RAS correlates with the strength of 
the senescence response. The mechanisms leading to OIS include hyperproliferation and altered 
DNA replication. This induces replication stress like firing of the DNA replication origins more 
than once per cell cycle resulting in stalled replication forks. Finally, the replication forks collapse 
leading to damaged DNA (Campisi 2005; Mallette and Ferbeyre 2007; Zhang 2007).
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Name Pathway Type and function 
TGF-β TGF signalling pathway Cytokine 
Interferon-β Antiviral response Cytokine 
XMRK Growth factors signalling pathway EGFR 
PTEN 
Inhibitor of growth factors signalling 
pathway Protein or lipid phosphatase 
RAS Growth-factor signalling pathway Membrane-associated small GTPase 
RAC1 Growth-factor signalling pathway Small GTPase 
RAF Growth-factor signalling pathway Protein kinase 
MOS Growth-factor signalling pathway Protein kinase 
MEK Growth-factor signalling pathway Protein kinase 
SMURF2 TGF signalling pathway SMAD-specific E3 ubiquitin ligase 
CDC6 DNA replication DNA replication licensing factor 
CYCLIN E Cell-cycle regulation CDK modulator 
STAT5 Growth-hormone signalling pathway Transcription factor 
MYC Transcription and DNA replication Transcription factor 
E2F Transcription Transcription factor 
Table 3 List of OIS inducers (Di Micco, Fumagalli et al. 2007) 
1.2.2.4 Mitochondrial Damage and Free Radical Theory 
In 1972 Dan Harman was the first to link aging with an increase in free radicals inside the cell. He 
based his theory on the concept that irradiation, which introduces free radicals in cells leads to 
mutations, aberrations, cancer and aging. Free radicals produced as an intermediate of 
mitochondrial respiration and cell metabolism throughout the life, thus should also imply in the 
mechanisms concerning aging. (Harman 1956) 
Free radicals or radical species (RS) are highly unstable molecules with an unpaired electron. The 
free electron reacts with organic molecules in the cell and thus modifies their original function. 
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Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are comprised of oxidizing 
agents that include a radical atom themselves or easily form radicals. The major RS are summarized 
in Table 4 (Wink and Mitchell 1998; Halliwell 2007) 
 
hydroxyl radicals OH
• 
superoxide radicals O2
•- radical centred molecules 
peroxyl radicals -OO
• 
peroxynitrite ONOO
- 
hypochlorus acid HOCl
- 
singlet oxygen 1O2 
ROS  
non-radical molecules 
hydrogen peroxide H2O2 
radical centred molecules nitric oxide NO
• 
nitrogen dioxide NO2 
nitryl chloride NO2Cl 
RNS 
non-radical molecules 
nitroxyl anion NO
- 
Table 4 Reactive oxygen and nitrogen species.  
Endogenous ROS are intermediates produced by oxidative enzymes of the electron transport chain 
during mitochondrial respiration (Figure 3). Oxidative phosphorylation establishes a membrane 
potential (∆ψm) along the inner mitochondrial membrane which is used for producing adenosin 
triphosphate (ATP). Also cellular metabolism with enzymatic reactions generates RS. Production of 
RS is used in signalling cascades and also in defence against microorganisms and inflammatory 
response by inducible nitric oxide synthase (iNOS) (Wink and Mitchell 1998; Starcevic, Diotte et 
al. 2003; Passos and Von Zglinicki 2006). 
Environmental RS reach from ionizing radiation, to UV light, but also include air pollution, 
smoking and toxic substances like asbestos. In vitro culturing of cells at 20% oxygen results in high 
oxidative stress and this situation resembles an in vivo hyperoxic situation. The effects of RS on the 
cells are numerous, including aggregation of lipid peroxidation, misfolded proteins, and DNA 
damage (Starcevic, Diotte et al. 2003). 
Lipid peroxidation disturbs cellular function as steroid hormones, fat soluble vitamins like retinoic 
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acids and prostaglandins, which connect surface receptors to the membrane and the cellular 
membranes themselves, are oxidized. This influences gene expression, protein synthesis and can 
even lead to protein cross linking. (Voss and Siems 2006) 
Oxidation of proteins primarily modifies amino acids and produces protein bound carbonyls which 
disrupt protein function and folding. Oxidized proteins are normally repaired or degraded by 
proteasomes. When damage occurs faster than proteins are repaired and degraded, oxidized proteins 
aggregate. A positive feed-back loop is started, as aggregates block the protease activity. The 
accumulated damaged proteins, also known as lipofuscin or age pigment, aggregate in cellular 
compartments (lysosomes). Lipofuscin binds transition metal irons and has autofluorescence 
capacity. Moreover, protein aggregates like Lewy bodies are involved in neurodegenerative 
diseases. Important for protein function is also their secondary and tertiary structure which is 
changed by RS. Oxidation of cysteine dissociates the important disulfide bridges found in many 
proteins. Metal irons, which are often coupled to active centres of enzymes, change their valence 
and thus the enzyme is inactivated. (Terman and Brunk 2006; Voss and Siems 2006) 
DNA is prone for oxidation. Next to direct DSB and single strand breaks (SSB), bases are damaged. 
The most known biomarker for oxidative damaged DNA is 8OHdG, which results from oxidation 
of guanine. When repair mechanisms are leaky, mutations result and these accumulate during cells 
age. Oxidized DNA forms adducts with organic molecules, further leading to DNA damage. 
Another important fact is that telomeres not only shorten each replicative cycle, but also are eroded 
because of oxidative stress. Mitochondrial DNA (mtDNA) is less protected than nuclear DNA and 
thus more prone for damage. Moreover, as no repair mechanisms exist for SSB in mitochondria, 
damage accumulates and results in dysfunction. This again starts a feed-back loop as damaged 
mitochondria show a higher risk of releasing radical intermediates which then in turn again damage 
the cell. (Passos, Saretzki et al. 2007) 
Cells have a variety of defence mechanisms to protect themselves from oxidative damage. The 
glutathione system, uric acid, vitamins and many enzymes with antioxidative properties are usually 
regulated according to the oxidative status of the cell. MnSOD, GPx1 and others are regulated by 
various stress sensoring proteins like p53. Still, the levels of oxidants and antioxidants determine 
the overall situation in the cells and deregulation leads to damage. 
Only lately methods have been found to measure oxidative stress in cells. This is done with reduced 
fluorescent dyes that are oxidized to their fluorescent form by RS. Moreover, dyes to prove 
functionality and mass of mitochondria have been developed. As explained before, dysfunctional 
mitochondria are inefficient as they release higher amounts of free radicals and produce less 
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amounts of ATP. Moreover, mitochondrial size increases and higher amounts of free radicals are 
produced, starting a positive feedback loop (Kurz, Decary et al. 2004). Mitochondrial membrane 
potential ∆ψm is measured with cationic dyes that change upon membrane potential shifts.  
 
Figure 3 Mitochondrial radical production and oxidative damage. Production of ATP in the mitochondria 
is linked to the establishment of a membrane potential (∆ψm) by the respiratory chain. Superoxide radicals 
are produced which damage metal-binding enzymes like aconitase. O2•- are scavenged via several steps by 
superoxide reductase, MnSOD, peroxiredoxin PrxIII and glutathione peroxidase GPX.  Further, this radical 
is reacting to produce hydroxyl radicals or, together with nitric oxide produce peroxynitrite. Oxidative stress 
leads to mtDNA damage, lipid peroxidation and aggregation of oxidized mitochondrial proteins.(Smith, 
Kelso et al. 2003) 
1.2.3 Pathways leading to Senescence 
Senescence is dependent on two major pathways: the p53-p21CIP and the p16INK4A-retinoblastoma 
(pRb) pathways (Toussaint, Medrano et al. 2000; Itahana, Campisi et al. 2007). The two pathways 
block proliferation independently but there is also cross talk between them as shown in Figure 4. In 
general, telomere shortening/erosion and other signals leading to a DNA damage response trigger 
the p53-p21 dependent pathway, which as a second step involves the p16-pRb pathway. On the 
other hand, senescence onset can act primarily through the p16-pRb pathway like in oxidative stress 
or oncogene induced senescence (Toussaint, Medrano et al. 2000). In the latter, especially 
oncogenic RAS leads to increased mitogenic signalling through the mitogen-activated protein 
kinase (MAPK) cascade.  
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Which pathway is primarily activated is dependent on the different cell types and senescence 
inducers. Epithelial cells rather induce the p16-pRb pathway while fibroblasts prefer the p53-p21 
cascade. Interestingly, in cultured cells it was shown that there is a high heterogeneity in between 
the same population as cells expressing mainly p16 were found next to cells expressing primarily 
p21. Inactivation of either or both pathways leads to an extended proliferative capacity of cells and 
tumour cells often show mutations in proteins involved in these pathways. (Itahana, Campisi et al. 
2007) 
 
Figure 4 Pathways leading to senescence and their interaction. (Ben-Porath and Weinberg 2004)  
1.2.3.1 DNA Damage Response and Repair 
Damage of DNA is a chemical and structural modification of genomic material. Carcinogenic 
substances induce DNA adduct formation by alkylation, oxidation, deamination and dimerization, 
but also SSB and DSB occur. Moreover, epigenetic patterns are changed leading to deregulation of 
gene expression. The most complicated damage to DNA is the DSB as it bears the danger to induce 
chromosomal aberrations and leads to the formation of micronuclei. (Holland, Frei et al. 2003; Obe 
and Vijayalaxmi 2007) 
There are six major mechanisms of DNA repair. DSB are mainly repaired by homologous 
recombination (HR) during late S-and G2-phase, or by non-homologous end joining (NHEJ). The 
other damages are repaired by direct DNA repair, mismatch repair, nucleotide- and base-excision 
repair.(Holland, Frei et al. 2003)  
Genomic integrity can only be maintained when DNA damage repair mechanisms are efficient. 
 
 
 
 
 
 
 
26 
Several diseases have been found to be linked to mutations in DNA repair signalling proteins like in 
ataxia-telangiectasia (AT), Bloom syndrome, Xeroderma pigmentosum and Fanconi anemia. 
Patients with these diseases have a higher risk of developing neoplasms and show premature aging 
compared to people showing normal DNA repair mechanisms. (Holland, Frei et al. 2003)  
Generally, for DNA damage repair like in Figure 2, sensor molecules like H2AX recognize the 
lesion. ATM and ATR are activated and recruited to the site of damage. These upstream kinases 
transduce the damage signal to mediator molecules (e.g. MDC1), downstream kinases (e.g. Chk1 
and Chk2) and to effector molecules (e.g. p53 and cdc25). Several mechanisms and signalling 
cascades are started, which result in blockage of the cell cycle, change of gene transcription, 
execution of apoptosis or senescence and of course in induction of different repair 
mechanisms.(Zhou and Elledge 2000; Campisi and d'Adda di Fagagna 2007) 
By experiments with fluorescence-tagged proteins the choreography of damage repair has been 
studied in detail. These damage repair proteins assemble at focal sites where DSB or HU induced 
replication stallings occur. (Lisby, Barlow et al. 2004; Lisby and Rothstein 2004; Lisby and 
Rothstein 2005)  
 
Figure 5 The DNA damage response. Many direct and indirect targets like kinases are involved in 
responding to damaged DNA. This then leads to cell cycle arrest and transcriptional change further on 
triggering apoptosis or repair (Zhou and Elledge 2000). 
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1.3 Experimental System: Senescence in MYCN Amplified 
Neuroblastoma Cell Lines 
In neoplasms, senescence is an important issue as many tumour cells overcome it to immortalize. 
This is achieved among others by increased telomerase activity, by oncogene amplification or by 
overriding apoptosis induction. Expression of tumour suppressor genes and growth inhibitor factors 
push the cell into a senescent phenotype. What has been shown in the past decade is that also 
oxidative stress, cytotoxic therapy and radiation therapy induce senescence in tumour cells. 
(Schmitt, Fridman et al. 2002; Roninson 2003) 
Senescence was suggested to be an antagonistic mechanism to tumour establishment (Campisi 
2005). It aroused high interest when in cultured neuroblastoma cell lines cells with morphologically 
senescent phenotype were found to occur spontaneously (Ambros and Ambros 2000).  
Generally, in MNA neuroblastoma cell lines morphologically distinct cell types - neuronal (N-cells) 
and flat (F-cells) cells - occur and sometimes also an intermediate type (I-cells) occurs. The 
published cell types show different cell morphology, proliferative capacity and expression patterns. 
(Ross, Spengler et al. 1983; Ambros, Rumpler et al. 1997; Spengler, Lazarova et al. 1997; Ross, 
Biedler et al. 2003)  
N-cells are morphologically described as cells with small cytoplasms. They show a phenotype with 
neuritic outgrowth and neurofilament triplet protein expression. More than 60% of the N-cells 
harbour high numbers of MYCN copies in the nucleus (Ambros, Rumpler et al. 1997). They also 
show MYCN positive micronuclei. Moreover, N-cells show high proliferative capacity with more 
than 40% of cells incorporating BrdU (120 minutes pulse). Transforming activities include a high 
telomerase activity abrogating replicative senescence and leading to limitless proliferative potential 
of these tumour cells. Moreover, the neoplastic feature of blocking apoptotic pathways in these 
neuroblastoma N-cells is suggested to result from epigenetic silencing of caspase 8 and from 
overexpression of Bcl-2, survivin and NM23. (Ambros, Rumpler et al. 1997; van Noesel and 
Versteeg 2004).  
N-cells can convert into another cell type - termed spontaneous senescent F-cells - without changing 
culturing parameters. This cell type forms up to 30 % of the untreated population (Ross, Spengler et 
al. 1983; Ambros, Rumpler et al. 1997). The conversion involves expulsion of amplified MYCN 
dmin into micronuclei. Thus spontaneous senescent cells are characterized by low MYCN copies 
and a flat morphology (Ambros, Rumpler et al. 1997). Their BrdU uptake decreases, suggesting 
them to have reduced proliferative capacities. Spontaneous senescent cells upregulate CD44 - a 
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favourable prognostic factor - and MHC-1 - which suggests acquired immunocompetent features. 
SA-β-Gal activity in spontaneous F-cells underscores the senescence phenotype. Together this 
suggests that spontaneous senescent  cells are tumour revertant (Ambros and Ambros 2000).  
Additionally, continual low dose HU treatment of cultured neuroblastoma cells induces the 
spontaneous senescent population and this population is referred to as induced senescent cells 
(Narath, Ambros et al. 2007). During treatment, an increase in micronuclei was observed which is 
suggested to lead to the loss of amplified MYCN (unpublished observations of our working group). 
Like spontaneous senescent cells, also the induced senescent cells showed decreased MYCN copy 
number. The generation of a pure induced senescent cell population was shown to take 6-8 weeks of 
continuous HU treatment. Similar to spontaneous senescent cells, also induced senescent cells 
showed features of tumour revertance: They incorporated less BrdU compared to an untreated 
population composed primarily of N-cells. Additionally, spontaneous senescent cells were shown to 
express CD44 and MHC-I, whereas telomerase activity was abrogated and telomeres were 
shortened. Induced senescent cells were, like spontaneous senescent cells, positive for the 
senescence marker SA-β-Gal. Narath et al. argued that senescence was established in induced 
senescent cells by replicative senescence as telomeres were shortened. Additionally, another 
unknown mechanism was suggested to contribute to MNA neuroblastoma cell senescence as 
replicative senescence takes longer than the 8 weeks, which were needed for induced senescent 
cells to form a pure population. (Narath, Ambros et al. 2007) 
1.4 Hydroxyurea, a Ribonucleotide Reductase Inhibitor 
Hydroxyurea (HU) is a drug that was first synthesized in 1869 and its mode of action was first 
described 1928. This small molecule shown in Figure 6 is used to treat patients with 
myeloproliferative diseases like chronic myelogenous leukemia. In solid tumours, HU is used alone 
or in combination with other genotoxic substances and IR to inhibit neoplastic proliferation. 
Further, in sickle-cell anaemia its usage prevents patients from crisis. Lately, HU was found to 
inhibit human immunodeficiency virus (HIV) type I DNA synthesis, suggesting an anti-viral 
application. (Szekeres, Fritzer-Szekeres et al. 1997; Holland, Frei et al. 2003)  
 
Figure 6 Chemical structure of Hydroxyurea (King 2003) 
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The mechanism of its action is only partly known. A recent study shed light on its in vivo 
metabolism and found that it produces nitric oxide (NO) (King 2003): Urease, an exclusively 
bacterial enzyme found in the gastric tract degrades HU to hydroxylamine, which can then be 
further reduced to NO in vivo. Moreover, both horseradish peroxidase and catalase catalyze the 
rapid formation of NO and nitroxyl (HNO) from HU. Heme or iron-bound proteins like cytochrome 
P450, catalase, aconitase and ribonucleotide reductase are inactivated. NO also reacts rapidly with 
superoxide (O2-) to form peroxynitrite, which disrupts protein structures through the nitration of 
protein tyrosine residues. The reaction generating NO and its intermediates is schematically shown 
in Figure 7. Moreover, production of peroxynitrite from mitochondrial superoxide and NO leads to 
depletion of ATP generation by blocking the electron transport chain. (Wink and Mitchell 1998; 
Holland, Frei et al. 2003; King 2003) 
 
Figure 7 Chemical oxidation of hydroxyurea (1) to NO and structures of the proposed intermediates: the 
nitroxide radical (2) and C-nitrosoformamide (3).(King 2003) 
HU enters the cell via passive diffusion. The main intracellular mode of action is inhibition of the 
enzyme ribonucleotide reductase (RNR). RNR catalyses the formation of deoxyribonucleotide 
triphosphate (dNTPs) from corresponding ribonucleotide triphosphate (NTPs), a reaction essential 
for DNA synthesis and repair in all living cells (Schrell, Rittig et al. 1997; Szekeres, Fritzer-
Szekeres et al. 1997). 
Active RNR is composed of 2 subunits, the large (RRM1) and optionally the small (RRM2) subunit 
in cycling cells or the p53 inducible subunit (RRM2B) during DNA repair and in G0/G1 arrested 
cells (Pontarin, Ferraro et al. 2007). The RRM1 gene was mapped to chromosome band 11p15.4 
and is cell cycle independently expressed. It contains a pair of thiol groups (-SH) at the catalytic site 
and has two allosteric sites for binding ATP and the small subunit RRM2. RRM2, encoded on 
chromosome band 2p25.1, is cell cycle specifically expressed. Levels rise in late G1- phase and 
peak in S-phase until in late mitosis it is ubiquitylated by the anaphase-promoting-complex (APC) 
followed by degradation.  
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RRM2B, located on chromosome 8p22.3 and its transcription is dependant on p53 induced by 
ultraviolet light, γ-irradiation or DNA-damaging agents. Other studies suggest a role of RRM2B in 
mitochondrial DNA replication, as cells with a mutated form show severe mtDNA 
depletion.(Bourdon, Minai et al. 2007)  
Both homologs, RRM2 and RRM2B harbour two iron binding centres and a stable organic free 
radical bound to a tyrosine in a hydrophobic pocket. Thus the main function in both is conserved, 
with the only difference that RRM2B was found to have lower affinities for binding RRM1.  
Two RRM1 and two RRM2 subunits assemble to form the active enzyme. The conversion of NTPs 
to dNTPs is a radical-based reaction step limiting in S-phase DNA synthesis, accomplished by 
reduction of the thioredoxin disulfide.  
HU is an iron chelator and radical scavenger. It inactivates both ribonucleotide small subunits by 
directly reducing the tyrosyl radical to a normal tyrosine residue via one-electron transfer from the 
drug. Moreover, also reduction of the iron centre leads to the release of this ferric compound from 
the protein. The inhibition is reversed significantly in the presence of iron, dithiothreitol (DTT) and 
oxygen. The regeneration was much more marked for RRM2B, resulting in a selective inhibition of 
RRM2 as compared to RRM2B.(Nordlund, Sjoberg et al. 1990; Holland, Frei et al. 2003; King 
2003; Shao, Zhou et al. 2006) 
 
1.5 Change in Nuclear Structure - Lamins  
The nucleus, the biggest compartment of the eukaryotic cell, is in charge of hosting the genetic 
material of the cell. Moreover, it serves as workspace for biosynthesis by transcription and splicing, 
and also contains numerous RNAs and proteins that conduct interactions in the cell. This highly 
specific organelle is surrounded by a nucleoskeleton comprising a nuclear envelope with nuclear 
pores, the outer nuclear membrane and the inner nuclear membrane. On the nucleoplasmic side of 
the inner nuclear membrane, a meshwork of proteins makes up the nuclear lamina. The proteins 
incorporated are the lamins, intermediate filaments of group V and lamin-associated proteins. The 
main function of the nuclear lamina is providing nuclear structure and organization. Lamin binding 
proteins serve as connection between chromatin and the nuclear envelop by which localisation and 
function of chromatin is regulated (Figure 8)(Foisner 2001; Mattout, Dechat et al. 2006). 
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Figure 8 Interconnections between lamins, associated proteins and chromatin at the nuclear envelope and 
in the nucleoplasm. (Foisner 2001) 
The structure of lamins and other intermediate filaments is a central helical rod domain flanked by a 
variable globular head and a globular tail domain (Figure 9) (Shumaker, Kuczmarski et al. 2003; 
Mattout, Dechat et al. 2006). 
 
Figure 9 Structure of Lamin A. The short, N-terminal head domain is shown in yellow, the central rod-like 
domain in blue, the C-terminal globular domain in red. The C-terminal truncated domain of prelamin A is 
shown in green.  
Lamins are encoded by 3 genes, LMNA, LMNB1 and LMNB2 that are located to chromosome band 
1q21.2-q21.3, 5q23.3-q31.1 and 19p13.3. They are grouped in A type and B type lamins according 
to their biochemical properties and function during mitosis. Generally, lamins depolymerise during 
mitosis. Neutral A type lamins are soluble during mitosis, while acidic B type lamins stay bound to 
the nuclear membrane. Shortly after cytokinesis, the nuclear lamina reassembles, lamin A getting 
incorporated later in G1-phase. (Gruenbaum, Margalit et al. 2005)  
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LMNA gives rise to four isoforms by variable splicing: lamin A, lamin A∆10, lamin C and lamin 
C2(Constantinescu, Gray et al. 2006). By post transcriptional modification steps of farnesylation 
and truncation of 18 amino acids of the C-terminal tail by the zinc metalloproteinase Ste24 
(Zmpste24), lamin A is processed into its mature form (Figure 10). Lamin A is primarily found in 
differentiated cells. Hematopoietic cell lines, embryonic cells and stem cells such as F9 
teratocarcinoma do not express lamin A/C (Rober, Sauter et al. 1990). This suggests the importance 
of cell plasticity to be negatively correlated with lamin A/C expression and thus its expression 
marks the stage of differentiation a cell has undergone. (Rober, Sauter et al. 1990; Constantinescu, 
Gray et al. 2006; Liu and Zhou 2008) 
 
Figure 10 The maturation of lamin A. Farnesyl-protein transferasere recognize the Cystein-aaX domain 
and adds a farnesyl group. This is the signal for the zinc metalloprotease Zmpste24, which cuts off the 3 C-
terminal amino acids (aaX) before a methylation step is performed. This step leads to a truncation of 15 
amino acids at the C-terminal tail domain by Zmpste24. (Kudlow, Kennedy et al. 2007) (Vlcek and Foisner 
2007) 
LMNB1 and LMNB2 give rise to the proteins lamin B1, B2 and B3. B1- and B2-type lamins are 
expressed ubiquitously in all cells. The non-canonical Lamin B3 is only expressed in 
spermatocytes.(Constantinescu, Gray et al. 2006; Liu and Zhou 2008) 
Many lamin binding proteins with a high range of functions have been found and suggest 
heterogeneous functions also for lamins. Next to LEM-domain proteins like emerin, LAP2α and 
LAP2β also BAF and LBR show functions related to senescence. LAP2α is one of three splicing 
variants encoded by the thymopoietin (TMPO) gene mapped to chromosome 2p22 (Harris, Andryuk 
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et al. 1994). The splicing product of TMPO gives rise to the 75kD nucleoplasmic protein 
thymopoietin alpha, or lamin associated protein alpha (LAP2α) and 5 transmembrane proteins, 
LAP2β - ζ. LAP2α is involved in the intranuclear chromatin architecture. Its N-terminal domain is 
conserved with the other LAP2 splicing variants, while the remaining LAP2α structure differs. By 
dimerization Lap2α binds to lamin A/C. The formed coiled-coil structures interact with pRb and 
thus plays a role in cell cycle regulation (Markiewicz, Dechat et al. 2002; Shumaker, Kuczmarski et 
al. 2003; Dechat, Gajewski et al. 2004; Dorner, Vlcek et al. 2006; Naetar, Hutter et al. 2007; 
Snyers, Vlcek et al. 2007) 
1.5.1 Lamins and Aging 
Monogenic hereditary diseases involved in premature or early aging are called progeroid 
syndromes. Mutated, progeroid-involved genes give insight into the mechanisms of aging. 
Hutchinson-Gilford progeria (HGPS) resembles a time-lapse aging phenotype but shows no signs of 
raised cancer rate or neurodegenerative diseases, as associated with physiological aging (Lans and 
Hoeijmakers 2006). The gene mutated in this autosomal dominant disorder is LMNA 
(predominantly G608G)(Liu and Zhou 2008). This mutation leads to a cryptic splicing site that 
serves as proteolytic cleavage site for Zmpste4 and results in an unmodified, truncated prelamin A, 
called progerin. Also many other mutations in the LMNA gene cause diseases and are summarized 
as laminopathies. The search of LMNA in the Online Mendelian Inheritance in Man database 
(OMIM) with the entry ID MIM *150330 links HGPS, limb girdle muscular dystrophy, dilated 
cardiomyopathy 1A, Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, 
lipoatrophy, Charcot-Marie-Tooth disease, Werner syndrome, mandibuloacral dysplasia and 
restrictive dermopathy (RD) to mutations in the LMNA gene (McKusick 2007). 
Lately, it was found that farnesylated lamin A is toxic to cells and leads to abnormal structure of the 
nuclear lamina with envelope interruptions and chromatin extrusions (Fong, Ng et al. 2004). 
Fibroblasts of HGPS patients show nuclear accumulated prelamin A leading to decreased exchange 
of lamin fibres (Gilchrist, Gilbert et al. 2004). 
Several lines of evidence suggest an involvement of LMNA in physiological aging processes. The 
connection of lamin A expression and physiological aging arose when premature aging in the HGPS 
was correlated with a mutation in the LMNA gene. Cleaved, farnesylated prelamin A is found in 
cells from HGPS patients. The same phenomena could be observed to a smaller extent in cells from 
old organisms, which also showed misshaped nuclei with lobes and invaginations. (Haithcock, 
Dayani et al. 2005; Lans and Hoeijmakers 2006; Scaffidi and Misteli 2006) 
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Usually, heterochromatic regions are structurally fixed and linked to the nuclear lamina. In HGPS 
patients, but also in late passage fibroblasts less heterochromatic markers are found which suggests 
lamin A to be associated with the epigenetic control of heterochromatin. Moreover, HGPS and late 
passage cells show loss of heterochromatin. (Shumaker, Kuczmarski et al. 2003; Gruenbaum, 
Margalit et al. 2005)  
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2 Material and Methods 
2.1 Cell Culture 
Neuroblastoma cell line STA-NB-9 (MNA, dmin) and STA-NB-10 (MNA, dmin) were cultivated 
in RPMI 1640 GlutaMAX (Gibco-BRL, Grand Island, New York, USA) supplemented with 10% 
fetal calf serum (FCS, PAA Laboratories GesmbH, Pasching, Austria), 2.5% HEPES (Gibco), 1% 
Sodium-Pyruvate (PAA Laboratories GesmbH), 0.6% Penicillin (10.000 U/ml)/Streptomycin (10 
mg/ml) (PAA Laboratories GesmbH) at 37°C in 5% CO2 until confluence. Splitting of the control 
cells occurred on average once a week. 
Cells were harvested by washing with phosphate-buffered saline (PBS, Invitrogen) following 
incubation with 0.5 - 2ml of Accutase (PAA Laboratories GesmbH) according to flask size at 37°C. 
The detached cells were resuspendend in a volume of medium at least triple amount of Accutase 
used. Cells are washed with PBS, or Accutase is inactivated by and kept in basic sorting buffer 
(PBS (Ca/Mg++ free), 1mM EDTA (Invitrogen), 25mM HEPES pH 7.0, 1%FCS, 0.02µm filter 
sterilized (Pall Life Sciences)). 
2.1.1 Hydroxyurea Treatment 
STA-NB-10 cells were treated with 150µM HU for 1 day to 10 weeks, whereas STA-NB-9 cells 
were treated with 75µM of HU when subconfluent. HU was renewed by changing half of the 
medium supplemented with freshly thawed HU at least once a week. In the control cells medium 
was changed averagely every 7 days.  
2.1.2 Comparison of H2O2 and HU Treatment in STA-NB-9 
STA-NB-9 cells were grown in a separate T-25 flask for each condition analyzed. Control cells 
were treated as explained and are referred to as untreated cells. H2O2 treatment was performed at a 
concentration of 75µM from a fresh stock dilution for 24 hours before harvesting the cells which 
are referred to as H2O2 induced cells. 24 hours treatment with HU was done in parallel and cells are 
referred to as induced cells. Thawed senescent cells were generated by 8 weeks HU induction 
followed by 3 weeks cultivation in HU-free medium before freezing and are referred to as induced 
senescent cells. 
Morphology change and SA-β-Gal activity, cell cycle and ROS level detection (MitoSox and DHE 
staining) were performed with the harvested population. 
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2.1.3 Time Course of STA-NB-10 Treated with HU for 0 – 70 days  
For each time point, STA-NB-10 cells were grown in a separate T-75 flask. Time points were at 0, 
1, 5, 10, 15, 56 and 70 days. Control cells were grown in parallel in a separate flask and are referred 
to as untreated cells. Cells treated for 1 – 15 days with HU are referred to as induced cells 
(induced). Additionally, the time of treatment is indicated. The following analyses were performed 
with the same cell population from one flask: cell cycle (until day 56), MYCN-FISH (0, 1, 10 and 70 
days), SA-β-Gal (until day 56), cellular superoxide levels (until day 56), lamin A/C and lamin B 
double fluorescence staining and protein isolation for western blotting (until day 56).  
For each time-point the flask was harvested, 1/10 of the cells were seeded in the original flasks to 
test for SA-β-Gal activity. From the remaining 9/10 of the population 1/10 was used to prepare 
cytospins (at least 2), 2/10 were used for superoxide assessment, and 2/10 were used for cell cycle 
analysis. The remaining 4/10 of the population were shock frozen as pellet and stored at -80°C for 
western blotting. 
2.1.4 Time Course of STA-NB-10 Treated with HU for 0 – 10 days  
For each time point, STA-NB-10 cells were grown in 6-well plates. Time points were at 0, 3, 6, 8 
and 10 days. Control cells were grown in parallel in separate wells and are referred to as untreated 
cells. Cells treated for 1 – 10 days with HU are referred to as induced cells. Cell cycle and growth 
curve were determined for each time point for treated and untreated cells. 
 
2.1.5 ROS Monitoring in STA-NB-9 (Newcastle) 
For ROS detection and analysis of mitochondrial function in STA-NB-9, untreated STA-NB-9 
(referred to as untreated cells), approximately 30-40 days HU treated cells (referred to as induced 
cells), and thawed senescent cells (referred to as induced senescent cells) were used. Senescent cells 
were generated by 8 weeks HU induction followed by 3 weeks cultivation in HU-free medium 
before freezing. Control cells, low passage MRC5 fibroblasts and senescent cells were cultivated in 
HU-free medium which was changed once a week. HU renewal was achieved by changing half the 
medium supplemented with 37.5µM HU every 4 days. Low passage MRC5 fibroblasts were a kind 
gift of the work group of T. von Zglinicki, Henry Wellcome Laboratory for Biogerontology 
Research in Newcastle. Experiments were also performed in the laboratory of T. von Zglinicki, 
supervised by J. Passos.  
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2.2 Microscopy Techniques 
2.2.1 Cytospin Preparation 
Accutase treated cells were harvested in PBS or basic sorting buffer and stored on ice until usage. 
Filter, funnel and holder were assembled on the glass slides and fixed with clamps. Filters were 
prewetted and then filled with 50 - 500µl of prevortexed cell suspension. With the cytocentrifuge 
(Shandon, Cheshire, United Kingdom) the cells were applied onto the slides at 500 rpm for 8 
minutes. The slide and filter/clipboard were cautiously taken apart and the slide was dried over 
night in provided boxes. Storage of these preparations was done either at RT for up to two weeks or 
at -20°C for several years in appropriate boxes. 
2.2.2 MYCN-Status Analysis 
When the thawed cell line was split the first time an aliquot of cell suspension was used for 
preparation of cytospins and a MYCN/2p FISH (see 2.2.3) was done to confirm that the amplified 
MYCN is present in the form of dmin.  
2.2.3 Double-target FISH 
Cytospin slides were fixed in 4% paraformaldehyde in PBS for 20 minutes at 4° C. After washing 2 
x 5 minutes in PBS cells are dehydrated in an EtOH series (70%, 90%, 95% EtOH for each 3 
minutes; further on referred to as EtOH series) and air dried. 1.5µl nick-labelled MYCN-dig and 2p-
bio probes (see 2.2.4) were applied to the cell spot, covered with a coverslip and sealed with rubber 
cement. Denaturation of the probe was achieved on the heating plate at 78°C for 8 minutes. The 
slides were hybridized overnight in a moist chamber in the heater at 37° C. Washing was performed 
5 minutes in 2 x SSC at RT, followed by 15 minutes 50% formamide in 2 x SSC at 42° C and 2 x 7 
minutes washing in 2 x SSC at 42°C. The probes were detected with antibodies against digoxigenin 
and biotin in 2% BSA (Sigma-Aldrich)/PBS by incubation in a moist chamber at 37° C for 30 
minutes followed by washing 2 x 7 minutes in 4 x SSC supplemented with 0.1% Tween 20 at 42° 
C. Secondary antibodies in 2% BSA/PBS were incubated in a moist chamber at 37°C for 30 
minutes followed again by the washing procedure described before. Fixation of the staining was 
achieved by incubation of the slides in 4% paraformaldehyde in PBS for 20 minutes at 4° C, 
followed by washing twice 5 minutes in PBS followed by dehydration in EtOH as above and air 
drying in the dark. Slides were mounted with Vectashield supplemented with DAPI and sealed with 
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rubber cement. Slides were analyzed with an Axioplan fluorescence microscope (Zeiss, Austria). 
2.2.4 Nick-labeling of FISH Probes 
The bacterial clones RP11-355H10 (AC010145, MYCN) and 08–103-1 (chromosome2p) were 
obtained from Dr. M. Rocchi (Resources for Molecular Cytogenetics, University of Bari, Italy). 2µg 
of extracted DNA, MYCN or 2pter, were combined with either DIG-Nick Translation Mix (Roche, 
Vienna, Austria) containing 0.08 mM digoxigenin-11-dUTP or Biotin-Nick Translation Mix 
(Roche, Vienna, Austria) containing 0.08 mM biotin-16-dUTP respectively and filled up with 
ddH2O to a total volume of 40µl. For direct labeling of MYCN with spectrum green the following 
labeling mix was prepared: 1,52µg MYCN DNA, 5µl DTT (Fisher Scientific, Applichem), 5µl 10x 
nick-translation buffer (0.5M Tris-HCl ph 8.0, 50mM MgCl, 0.5 mg/ml BSA pH 7.8), 5µl 
nucleotides (Sigma-Aldrich), 1µl Spectrum Green-dUTP (Abbott, Vysis), 5µl DNase (1:1000) 
(Roche), 1,5µl DNA Polymerase (8U/µl) (Promega) filled up to a total volume of 50µl with water. 
The solutions were incubated for 120 minutes at 16°C (direct labeling 2h at 15°C). To verify 
labeling and size (MYCN: 200 Kb) of the probes, a 1.2% agarose gel was run 40 minutes at 100V 
and 500mA with 5µl sample added to 1µl loading buffer. Meanwhile the probes were kept on ice so 
that further nick labeling remains possible. The reaction was stopped by addition of 30µg of COT 
human DNA (Roche Diagnostics GmbH, Mannheim, Germany), a volume of NaAc (3M, pH 5.5) 
calculated as 1/10 of the probe volume plus the COT DNA volume and 2.5 times the volume of the 
solution of 100% EtOH. Precipitation of labeled DNA probes is achieved by incubation at -70° for a 
minimum of 30 minutes followed by a centrifugation step (30 minutes at 13000 rpm at 4°C). After 
removal of the supernatant the pellet was resuspended in 70% EtOH followed by centrifugation for 
15 minutes at 13000 at 4°C. The supernatant was removed carefully and the DNA pellet was dried. 
Resuspension of the probe was done in 40µl of hybridization mix (200µl formamide, 100µl 20x 
SCC, 200µl dextransulfate and 200µl distilled water). 
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Figure 11 Ensembl chromosome map showing the location of the MYCN clone used in FISH experiments. 
2.2.5 Interphase FISH with Simultaneous Immunofluorescence 
Cytospin slides were incubated in PBS for 5 minutes and afterwards fixed in 4% precooled 
paraformaldehyde (Roth, Austria) at 4°C for 20 minutes. After 5 steps of each 3 minutes washing in 
PBS (further defined as washing step) the preparations were incubated with filtered (pore size: 
0.2µm) 5% BSA in PBS for 30 minutes in a humid chamber at 37°C. Further on the cells were 
incubated with the lamin A/C or lamin B antibody diluted 1:100 in the 5% BSA solution for 60 - 
120 minutes in a humid chamber at 37°C. Following the washing step the cells were incubated with 
the secondary rabbit anti mouse-TRITC antibody for 30 minutes (37°C, humid chamber), followed 
by another washing step. The immune fluorescence staining was then fixed in 4% 
paraformaldehyde for 20 minutes. After 2 x 5 minutes washing with PBS the preparations were 
dehydrated (EtOH series) and air dried (in the dark). 1.5µl of the direct-spectrum green labeled 
MYCN-probe were applied onto the cells, covered with a coverslip and sealed with fixogum. DNA 
denaturation was accomplished by putting the slides onto a heating plate (78°C) for 8 minutes, 
followed by hybridization over night in a humid chamber at 37°C. After removing the coverslip 
form the slide, the cells were washed 5 minutes in 2xSSC at room temperature, 5 minutes at 50% 
formamide in 2xSSC at 42°C and another 5 minutes in 2xSSC at 42°C. Before dehydration (EtOH 
series), the cells were washed 5x3 minutes in PBS. After drying of the preparations, the slides were 
mounted with Vectashield supplemented with DAPI and cover slips were sealed with rubber cement 
(Fixogum). Slides were analyzed with an Axioplan 2 fluorescence microscope (Zeiss, Austria) 
using the Metafer4-MetaCyte and Isis software (both MetaSystems, Altlussheim, Germany). 
 
 
 
 
 
 
 
40 
2.2.6 Immunofluorescence microscopy 
Cytospin slides and grown cell preparations were fixed in 4% paraformaldehyde in PBS for 20 
minutes at 4° C. After washing (3 x 5 minutes in PBS) unspecific binding sites were blocked in 2% 
BSA in PBS at 37°C for 30 minutes in a humid chamber. Primary antibody incubation was 
performed for 1 hour at 37°C in a humid chamber. After 3 washing steps, each 5 minutes in PBS the 
fluorophore-conjugated secondary antibody was incubated for 30 minutes in a humid chamber at 
37°C. The antibodies and the used concentrations are depicted in Table 5. After 3 passes of 
washing, cells were mounted with 10µl Vectashield mounting medium supplemented with DAPI 
(Axxora) and coverslips were sealed with Fixogum rubber cement (Marabu). 
According to preexperiments done to determine optimal staining conditions and staining results, 
different slightly adapted standard immune fluorescence protocols were established. Preexperiments 
included different fixatives (MeOH, -20°C; EtOH/Acetate, RT; PFA, -4°C or RT), preextraction 
and permeabilisation steps (different concentrations of Triton X 100 or Tween, different duration).  
The above describes standard protocol was used for lamin A/C, lamin B, nuclear pore complex 
(mAb414), LAP2α, BrdU, MYCN-dig and all double stainings with CD44. For prelamin A single 
staining, preextraction was performed by incubation of rehydrated cytospin preparations with 0.5% 
TXT for 10 minutes. After the fixation step, permeabilisation was performed in 0.1% TXT100 for 5 
minutes at room temperature.  
Slides were analyzed with an Axioplan fluorescence microscope (Zeiss, Austria) and images were 
taken with a high resolution CCD camera with the ISIS software (MetaSystems, Altlussheim, 
Germany). 
2.2.7 Senescence-Associated β-Galactosidase Activity Assay 
Cells in flasks were washed with PBS, and the senescence detection kit (BioVision, Mountain 
View, USA) was used following the protocol supplied by the company as follows: Cells were fixed 
with 200 µl 0.2% glutaraldehyde for 15 minutes at room temperature. The cells were washed in 
PBS, covered and incubated with freshly prepared X-gal solution (containing 10 mM phosphate 
buffer, 150 mM NaCl, 1 mM MgCl2, 3.3 mM K4Fe(CN)63H2O, 3.3 mM K3Fe(CN)6, and 0.2% 5-
bromo-4-chloro-3-indolyl-b-galactropyranosid) overnight. After rinsing the cells in the flask with 
PBS cells were analyzed with an Axiovert 135 inverted fluorescence DIC microscope (Zeiss, 
Austria ) and pictures were taken with a CCD camera and the associated software (PixeLINK, 
Ottawa, USA). 
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2.3 Flow Cytometry 
2.3.1 Growth Curve 
5 x 105 STA-NB-10 cells were seeded in 6-well-plates. Two days later, the medium was exchanged 
with HU-supplemented medium (150µM) or for control cells with HU-free medium. After 0, 1, 3, 
6, 8 and 10 days cells were harvested and transferred to tubes in basic sorting buffer. 20µl of the 
cell suspension were mixed with 10 ml Isoton (Beckman Coulter) and 4 drops of ZapoGlobin II 
lytic reagent (Beckmann Coulter) and cell number was counted in the Coulter counter (Beckmann 
Coulter). The remaining cells were used for cell cycle analysis. For calculating population doubling 
time, the following equation was used: 
 
Td = period of time x log (2)/log (population output/population input) 
2.3.2 Cell Cycle Analysis 
DNA staining according to cell cycle stage was performed with the Cycle Test Plus –DNA reagent 
kit (Becton Dickinson Co., Mountain View, CA) according to the manufacturer’s protocol. A cell 
pellet of 1x106 cells was resuspended in 700µl dimethylsulfoxide (DMSO) in sucrose-sodium 
citrate. Permeabilisation of the cells was performed by incubation in 125 µl of prewarmed trypsin in 
spermine tetrahydrochloride detergent buffer 10 minutes at room temperature. Permeabilisation 
inactivation was done by incubation with 90µl RNase A and trypsin inhibitor in spermine buffer. 
Staining of DNA was performed with propidium iodide (PI) in spermine buffer for 10 minutes on 
ice followed by centrifugation of the cells. Detection was performed with a FACScan flow 
cytometer (Becton Dickinson Co, Mountain View, CA). 
2.3.3 Proliferation Assay 
5 x 105 cells were seeded per well into a 6-well plate. After two days HU supplemented medium 
was added for STA-NB-9 at a concentration of 75µM and for STA-NB-10 at a concentration of 
150µM. 10µM BrdU was added to each well. Control cells were cultivated in HU-free, BrdU 
containing medium. After 24 hours incubation with both substances cells were harvested and 
cytospin preparations were prepared. Detection of incorporated BrdU was done according to 
standard immune fluorescence protocol. BrdU positive cells were counted with an Axioplan 
fluorescence microscope (Zeiss, Austria). 
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2.3.4 Analysis of Reactive Oxygen Species (Cellular Superoxide, Cellular 
Peroxide and Peroxinitrite Levels) 
Three tubes with each approximately 2 x 105 cells were prepared (negative control and stained 
sample). Cells were centrifuged at 1500rpm for 3.5 minutes, the supernatant was aspirated and the 
cells were resuspended in either MitoSOX Red mitochondrial superoxide indicator (5µM, 
Molecular Probes) or Dihydrorhodamine 123 (DHR, 30µM, Molecular Probes). Incubation time 
was 10 minutes and 30 minutes, respectively at 37°C followed by centrifugation at 1500rpm for 3.5 
minutes. Resuspension of the stained cell pellet was performed in 2ml serum free medium. DHR 
was excited at 488nm and was detected at 530 nm (FL1). MitoSox was excited at 488 – 514nm and 
detected at 670 nm (FL3). Median fluorescence intensity was measured with the Partec PAS flow 
cytometer (Partec GmbH, Münster, Germany) and analysed with the Partec FloMax software 
(Partec GmbH, Münster, Germany). The flow cytometer was calibrated using fluorescent beads. All 
data are mean ± standard error of mean from 5 independent experiments with measurements in 
duplicate. 
For the time course experiment with STA-NB-10 (chapter 2.1.3) and for STA-NB-9 experiment 
comparing HU to H2O2 (chapter 2.1.2) only MitoSox Red was used. The procedure was the same as 
described above except for using a FACScan flow cytometer (Becton Dickinson Co, Mountain 
View, CA) for detection and analysis. 
2.3.5 Analysis of Mitochondrial Membrane Potential and Mitochondrial Mass 
Cells were harvested, counted and three tubes with each 2 x 105 cells were prepared (negative 
control and stained sample). Cells were centrifuged at 1500rpm for 3.5 minutes, the supernatant was 
aspirated and the cells were resuspended in either 10-N-nonyl acridine orange (NAO, 10µM, 
Molecular Probes) or 5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolyl-carbocyanine iodide 
(JC-1, 1µg/ml, Molecular Probes). Incubation time was 10 minutes and 30 minutes respectively at 
37°C, followed by centrifugation at 1500rpm for 3.5 minutes. Resuspension of the stained cell 
pellet was performed in 2ml serum free medium. NAO was excited at 488nm and was detected at 
530 nm (FL1). JC-1 was excited at 488nm and was detected at 530 nm (FL1) and at 670 nm (FL3). 
The FL3/FL1 ratio was calculated for JC-1. Analysis was done with the Partec PAS flow cytometer 
(Partec GmbH, Münster, Germany) and analysed with the Partec FloMax software (Partec GmbH, 
Münster, Germany). The flow cytometer was calibrated using fluorescent beads. All data are mean 
± standard error of mean from 3 independent experiments with measurements in duplicate. 
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2.4 Protein Analysis 
2.4.1 Western Blot 
Cells were harvested, centrifuged at 1100 rpm for 10 minutes and washed once with PBS before 
shock freezing the pellet in liquid nitrogen. After thawing, the cell pellets were lysed and 
resuspended in 100 – 150µl of 2x loading buffer plus the same volume of PBS followed by boiling 
the sample for 15 minutes at 95°C. To define the amount of proteins in the probes a 10% SDS gel 
was loaded with samples diluted to half the concentration with 1x loading buffer and run at 
70mV(limiting) for 1 hour. The samples were prepared as following: 10µl 2x sample buffer was 
added to 10µl lysed protein or 5µl of broad band range prestained protein marker (Biolabs, Ipswich, 
UK), 15 minutes at 95°C (only 5 minutes for the marker), 5 minutes at 13000 rpm. Blotting of the 
gel was performed with a nitrocellulose membrane between 3 filter papers soaked in transfer buffer. 
Blotting was achieved at constant 400mV/gel for 1.5 hours on ice. The membrane was stained with 
ponceau, the staining was scanned and integrated intensity measurements were performed using 
ImageJ software. Protein levels present in the samples were calculated and normalized. 
Equal amounts of protein from each lysate were resolved by SDS–PAGE and transferred to the 
membrane and stained with ponceau as described above. Unspecific binding sites were blocked 
with 1% skim milk in PBS for at least 60 minutes, shaking at RT. The membrane was incubated 
with the primary antibodies in 0.5% skim milk over night at 4°C shaking. The blots were washed 6 
times 10 minutes with TBS-Tween. Incubation with the secondary antibody (Pierce Biotechnology) 
diluted in ODYSSEY blocking buffer was performed for 1 hour at room temperature shaking. The 
antibodies and the used concentrations are depicted in Table 5. The blots were washed again 6 times 
15 minutes with TBS-Tween. Detection was performed with the LI-COR ODYSSEY system. 
Further, integrated density measurements were performed with ImageJ. As senescent cells change 
their gene expression for most reference house-keeping genes as indicated by microarray analysis, 
the integrated density of the ponceau staining was taken as loading control. 
 
 
 
 
 
 
 
44 
 
Antibody against dilution species Company 
LaminA/C (636) 1:100 mouse monoclonal Santa Cruz biotechnology, Inc. 
Lamin B (C-20) 1:100 goat polyclonal Santa Cruz biotechnology, Inc. 
prelamin A (C-209) 1:50 goat polyclonal Santa Cruz biotechnology, Inc. 
LAP2a 1:250 rabbit polyclonal ImmuQuest Ltd 
MAb414 1:100 mouse monoclonal Abcam Ltd 
CD44, Phagocytic 
Glycoprotein-1 1:30 mouse monoclonal DakoCytomation, Vienna, Austria 
MYCN 1:100 mouse monoclonal Abcam 
p53 (DO1) 1:10 mouse serum 
B. Vojtesek (Masaryk Memorial Cancer 
Institute, Brno, Czech Republic). 
p21 (F5) 1:70 mouse monoclonal Santa Cruz biotechnology, Inc 
p16 (F12) 1:200 mouse monoclonal Santa Cruz biotechnology, Inc. 
pRb (IF8) 1:200 mouse monoclonal Santa Cruz biotechnology, Inc. 
BrdU 1:100 mouse BD 
digoxigenin- FITC 1:100 sheep 
Enzo Life Sciences, Inc., Farmingdale, 
NY 
biotin-TRITC 1:100 mouse  
sheep Ig- FITC 1:100 rabbit DakoCytomation, Vienna, Austria 
mouse Ig- TRITC 1:40 rabbit DakoCytomation, Vienna, Austria 
mouse Ig- FITC 1:60 rabbit DakoCytomation, Vienna, Austria 
goat IgG- TRITC 1:40 rabbit Jackson Immuno Research 
rabbit IgG- TRITC 1:30 swine DakoCytomation, Vienna, Austria 
mouse IgG –DyLight 
800 (infrared) 1:8000 goat Pierce Biotechnology 
Table 5. List of antibodies used. 
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3 Aim of the study 
The aim of this study was to investigate candidate pathways and changes involved in HU-induced 
senescence of MNA NB cells.  
In the first part of the study the changes brought about by low dose HU treatment of neuroblastoma 
cells concerning population growth, cell cycle behaviour and MYCN copy number were assessed. 
Additionally, the senescence typical markers SA-β-Gal activity and morphology change were 
monitored to have an indicator for senescence after low dose HU treatment.  
As second part, involvement of ROS and mitochondrial function during the onset of tumour cell 
senescence after low dose HU treatment was assessed. The idea behind was to find the direct effects 
of HU treatment on the cell and the indirect effects corresponding to premature senescence onset.  
As third part of the study, the composition of the nuclear envelope and associated proteins were 
assessed following low dose HU treatment of neuroblastoma cells. Additionally, spontaneous F-
cells were compared to N-cells to learn about the differences in components of the nuclear lamina 
and of the nucleoplasm like lamin A/C, prelamin A, lamin B, LAP2α and nuclear pore complexes. 
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4 Results 
4.1 Markers of Senescence: Cell Morphology and SA-β-Gal Activity 
To prove that the onset of senescence is induced in neuroblastoma cells by long term low dose 
treatment with HU, the main marker for senescence, SA-β-Gal activity was assayed on untreated, 
HU induced and HU induced senescent cell populations. Additionally, the change in morphology 
was observed. These indicators of senescence were documented by images taken in the phase 
contrast or bright field of an inverted DIC fluorescence microscope with 10x and 20x magnifying 
objectives coupled to a CCD camera.  
In Figure 12 STA-NB-9 cells treated according to the protocol with X-gal and assayed for positivity 
are depicted. Terminology and type of treatment are referred to in detail in chapter 2.1.2. Small cells 
with scant cytoplasms and neurite outgrowth (N-cells) were found to be SA-β-Gal negative, 
whereas cells with flat morphology and high granularity (F-cells) were found in the induced and 
senescent population and were positive for SA-ß-Gal staining. In Figure 12A, an untreated 
population is depicted. Typical N-cells show no blue staining. Spontaneous F-cells, with F-cell 
morphology were seen infrequently and were positive for SA-β-Gal. In Figure 12B, ind-cells show 
no significantly higher fraction of F-cells and SA-β-Gal staining - indicated here by the blue 
staining beneath the N-cell layer. In Figure 12C induced cells are depicted, consisting of cells with 
flat morphology and showing SA-β-Gal positive staining. In Figure 12D H2O2 induced cells show a 
markedly higher proportion of cells with flat morphology compared to the HU induced cells. In 
H2O2-induced cells, induced cells and induced senescent cells SA-β-Gal staining is shown on cells 
with flat morphology, while cells with neurite outgrowth and scant cytoplasm are not stained. 
To assess the time point of change in morphology and SA-β-gal expression a time course 
experiment was performed with STA-NB-10 cell line explained in detail in chapter 2.1.2 (Figure 
13). The untreated population was compared to induced cells (1, 5, 10 and 15 days after the start of 
HU treatment) and induced senescent cells. Untreated cells (Figure 13A) contained primarily a 
population of small cells with scant cytoplasm and neurite outgrowth. Only a low number of cells 
with flat morphology were observed in the untreated population. N-cells showed no SA-β-Gal 
staining whereas the flat cells showed blue staining. N-cells pretending to be positively stained were 
adhering to positive F-cells. 
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Figure 12 STA-NB-9 cells acquiring the senescent morphology showed senescence-associated-β-
galactosidase activity (SA-β-Gal). Images of untreated cells A induced cells B induced senescent C and 
H2O2 induced D cells were taken with a CCD camera coupled to an inverted fluorescence DIC microscope 
before staining by phase contrast a) and after SA-β-Gal staining by bright field b) imaging. 
With HU treatment, N-cell population of induced cells decreased and a high proportion of cell 
debris was found in the medium. In cells induced for 10 days (Figure 13D) and 15 days (Figure 
13E) a third cell type, next to F-cells and N-cells appeared in the flasks. This cell type clustered and 
formed neurite networks connecting to the surrounding cells, resembling typical features of 
differentiating neuroblastoma cells. In induced senescent cells (Figure 13F) a small proportion of 
cells with differentiating features was present. SA-β-Gal positive staining was in all time points 
only found in morphological flat cells which did not show neurite outgrowth. The proportion of cell 
types varied between different flasks for different time points, but a general trend was that cells 
with neurite outgrowth declined. During treatment the amount of cells with flat morphology and 
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cells with features of differentiation increased. In late stages of induction - from 6 weeks onwards 
(only treatment for 56 days is shown) -the amount of differentiating cells decreased and SA-β-Gal 
positive cells with flat, enlarged morphology remained.  
 
Figure 13. STA-NB-10 cells 
acquiring the flat, enlarged 
morphology showed senescence-
associated-β-galactosidase activity 
(SA-β-Gal). Images of untreated cells 
A inducedcells treated for 1 day B, 5 
days C, 10 days D, and 15 days E 
with HU, as well as of induced 
senescent cells treated for 56 days F 
were taken with a CCD camera 
coupled to an inverted fluorescence 
DIC microscope before staining by 
phase contrast a) and after SA-β-Gal 
staining by bright field b) imaging. 
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4.2 Proliferation, Growth and Cell Cycle Assay, MYCN Copy Number 
4.2.1 Cell Cycle Analyses 
Next to the assessment of the senescence typical morphology and senescence marker SA-β-Gal, the 
cell cycle was monitored by staining cells with BD cell cycle test and measuring DNA content with 
flow cytometry. 
In Figure 14 the cell cycle of asynchronous STA-NB-9 cells induced for 24 hours with HU 
(induced) or H2O2 (H2O2 induced), and induced until senescence with HU (induced senescent) is 
depicted. Details about the experimental setup are described in chapter 2.1.2. The treatment with 
either HU or H2O2 insignificantly increases the G1-population and decreases the S-phase 
population. Moreover, HU depletes cells with G2/M-DNA content while in H2O2 induced cells this 
population does not decline. However, induced senescent cells show a high proportion of cells in 
G1-phase (92%) and only 8% of the cells remain in S-phase. Interestingly, neither induced nor 
induced senescent cells were detected to have a G2/M-phase DNA content. 
 
Figure 14. Cell cycle of STA-NB-9 cells after induction. Untreated cells, 24 hours HU treated (induced), 
HU induced senescent cells (induced senescent) and 24 hours H2O2 treated cells (H2O2 induced) were 
assessed for G1-phase (G1), S-phase (S) and G2-phase/mitosis (G2) of the cell cycle.  
STA-NB-10 cell line was assessed in more detail for changes in the cell cycle with time. In Figure 
15 and Figure 16 the amount of cells detected for either G1-, S- or G2/M-phase of the cell cycle 
were monitored. From the time course experiment explained in detail in chapters 2.1.2, aliquots 
were monitored for their cell cycle pattern (Figure 15). The untreated population was made up of 
66% of cells with G1-phase-, 28% with S-phase- and 6% with G2/M-DNA content. After 1-5 days 
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of HU induction an increase in the S-phase population was observed (day1 35% and day 5 43%). 
This shift of the population was observed along with a decrease in G1-phase (d1= 61%, d5=51%). 
From day 10 of induction, a consistent increase in G1-phase was observed, reaching up to 80% after 
56 days. At this time point only 6% of the population remained in S-phase.  
In Figure 16 the effect of HU treatment on the first ten days were assessed in detail. 1, 3, 6, 8 and 10 
days induced cells were stained with BD cell cycle test and assessed by FACS. Untreated cells were 
analysed in paralell to compensate for systematic errors (Figure 16A). During the analysis, the 
untreated cell population showed no significant change in cell cycle. The mean proportion of cells 
in S-phase were 26% and in G1-phase 70%, while 5% of the cells were in G2/M-phase. When such 
cell populations were treated with HU (Figure 16B), an increase in the S-phase population was 
observed on day 1 (S-phase = 51%) with a decrease in G1-phase (G1= 46%). From day 3 of 
induction, the G1-phase population increased and the proportion of cells in S-phase decreased. 
After 10 days treatment with HU the cell population showed 73% G1-phase, 20% S-phase and 7% 
G2/M-phase.  
 
Figure 15 Cell cycle of STA-NB-10 cells in a time course after induction. Untreated cells (0 days) and HU 
induced cells (1 – 56 days) were assessed for G1-phase (G1), S-phase (S) and G2/M-phase (G2) of the cell 
cycle. 
4.2.2 Growth Curve 
To assess the growth curve and population doublings of the cells which were taken for the 
experiment depicted in Figure 16A and B, the cell number was counted with a coulter counter and is 
shown in Figure 16C. A starting population of 5 x 105 cells was assessed over 10 days following 
HU treatment. In parallel an untreated population was assessed. Doubling of untreated 
neuroblastoma cells was calculated to occur every 3 days. To the contrary, HU treatment decimates 
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the cell population to 2.4 x 105 cells representing approximately half of the original cell number. 
 
Figure 16 Cell cycle and growth curve of STA-NB-10 cells for 10 days after induction. Untreated cells A 
and HU induced cells B were assessed for G1-phase (G1), S-phase (S) and G2/M-phase (G2) of the cell 
cycle in parallel. C Growth curve of the untreated cell population (triangle) was compared to HU induced 
cell population (square) for 10 days. 
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4.2.2.1 Proliferation Assay 
To further assess the high increase in S-phase after the first 24 hours of HU treatment in STA-NB-
10 cells, the neuroblastoma cells were assessed for BrdU uptake over 24 hours. In Figure 17 the 
effects of HU treatment on entering S-phase during 24 hours was compared to untreated control 
cells (Figure 17). After 24 hours treatment with HU in BrdU supplemented medium cells showed 
the same proportion of replicating cells as the control. The cells proliferating are for untreated and 
treated cells approximately 46% of at least 890 cells counted. Around 54% of the cells did not show 
BrdU positivity.  
 
4.2.3 MYCN Amplification Status 
The copy number of the MYCN gene in the time course of low dose HU treatment (150µM) of the 
MYCN amplified neuroblastoma cell line STA-NB-10 was evaluated (Figure 18). Direct MYCN-
interphase-FISH was performed on cytospin preparations of the treated cell populations. FISH spot 
counting was performed by automatic microscopy with the Metafer Metacyte program. Results are 
shown as percentage of total counted cells which were 709 cells for untreated control, 634 for 1 day 
treated cells, 481 for 10 days treated cells and 286 cells for 70 days treated cells. Cells are classified 
according to Ambros et al. with one or two copies being normal, 3 to 8 MYCN copies - up to 4-fold 
increase relative to reference signals - per cell signifying gain of MYCN and more than 8 copies - > 
4-fold increase relative to reference signals - showing gene amplification (Ambros, Benard et al. 
2003). In untreated neuroblastoma cells 73% of the cells had more than 8 copies of MYCN, whereas 
less than 3% of the cells displayed normal MYCN copy numbers. 24 hours HU treated cells showed 
a smaller percentage of amplified cells (67%) and a not significant higher percentage of cells with a 
MYCN gain (from 24.4% to 30.6%). In the 10 days HU treated cell population 26% of the cells 
show amplified status, whereas 50% show a gain of MYCN and 17.5% show a normal phenotype. In 
Figure 17. HU treatment does 
not affect BrdU incorporation 
during 24 hours. Proliferation 
was assayed in asynchronous 
STA-NB-10 populations. 1456 
HU induced cells and 890 
untreated cells were assessed in 
parallel for BrdU incorporation 
during 24h. The percentage of 
the population positive (BrdU+) 
and negative (BrdU-) for BrdU 
is depicted. 
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contrast to our expectations, the population treated for 70 days showed a higher percentage of cells 
with amplification (42.3%) compared to 10 days induced cells. The majority of the 70 days induced 
cells showed MYCN gain. 15.7% of the population showed a normal MYCN status, which is a 5.6-
fold increase compared to the untreated control.  
 
Figure 18 Decrease of MYCN copy number following HU treatment. Direct MYCN-interphase-FISH was 
performed on cells induced for different periods of time. After HU induction automatic spot counting was 
performed. Results are shown as percentage of total counted cells. 
4.3 Investigation of ROS Involving Mitochondrial Function in 
Neuroblastoma Cells Undergoing a Senescent Phenotype after HU 
Treatment 
Here we tested whether the treatment with HU and the induction of senescence provokes an 
increase in superoxide, peroxynitrite, mitochondrial membrane potential ∆ψm and mitochondrial 
mass. Therefore, cells induced for different amounts of time with HU (or with H2O2 for 24 hours), 
as well as different cell lines (STA-NB-9, STA-NB-10, MRC5) were stained with specific dyes. 
Analysis was performed by flow cytometry and/or by live cell imaging with a confocal microscope. 
4.3.1 Change in Superoxide Levels 
To measure superoxide levels (Figure 19), at least 35 days HU treated (induced), induced senescent 
and control STA-NB-9 (untreated) populations were stained with MitoSox Red mitochondrial 
superoxide dye. Details about treatment of cells and staining method are described in chapter 2.1.5 
and 2.3.4. Flow cytometric analysis (Figure 19A) of induced and induced senescent cells showed a 
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more than two fold increase (2.4 and 2.7 respectively) in intensity. All data are relative values ± 
standard error of mean from 5 independent experiments with measurements in duplicate. The 
asterisk indicates a significant difference to the control (p < 0.05) determined by paired two-tailed t-
test. Relative fluorescence intensity of untreated cells is comparable to the fluorescence intensity of 
MRC5 fibroblasts. Slide grown live STA-NB-9 cells (Figure 19B) were imaged by confocal light 
microscopy.  
 
Figure 19. Increase in superoxide levels. A Relative fluorescence intensity of MitoSox Red in untreated 
STA-NB-9 cells (relative fluorescence intensity of 1), HU induced cells (induced), HU induced senescent 
cells (induced senescent) and MRC5 fibroblasts was measured by FACS. Asterisk indicates significance 
p<0.05. B Fluorescence and phase contrast images of untreated a), induced b) and induced senescent c) STA-
NB-9 neuroblastoma cells are depicted. Cell debris or apoptotic cells were unspecifically stained).  
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Typical cells of untreated control cells were taken with a 63x magnification objective while the 
images of the typical HU treated and induced senescent cells were taken with 40x. Untreated cells 
show small cytoplasm and neuronal outgrowth. These cells show little MitoSox staining (red), but 
unspecific background staining shows high fluorescence intensity. Induced cells show increased 
fluorescence intensity. Moreover, the morphology of induced cells changes to a flat morphology 
and cytoplasms enlarge compared to untreated cells. Induced senescent cells show the largest 
cytoplasms of the three compared populations. Bright fluorescent staining is localized to the 
cytoplasm leaving the nucleus unstained. 
Figure 20. Increase in ROS 
after 24 hours treatment. 
MitoSOX was measured in 
STA-NB-9 cells treated for 1 
day with HU or H2O2. Moreover 
untreated control cells were 
stained and analysed by 
FACS. HU shows the same 
potential to induce cellular 
superoxide as H2O2. 
 
 
 
Following the initial experiment, the time of superoxide increase and comparison of the radical 
inducer H2O2 to HU after 24 hours treatment were analysed with the same method. Therefore, STA-
NB-9 cells were induced for 24 hours with HU. Hydrogen peroxide (H2O2), itself a ROS, was used 
as a positive indicator of cellular oxidative stress and treatment was done for 24 hours with 75µM 
H2O2. These differentially conditioned cells were stained with MitoSOX Red superoxide indicator 
according to the protocol (chapter 2.1.1) and were analysed by FACS. In Figure 19Typical cells of 
untreated control cells were taken with a 63x magnification objective while the images of the 
typical HU treated and induced senescent cells were taken with 40x. Untreated cells show small 
cytoplasm and neuronal outgrowth. These cells show little MitoSox, relative values to the untreated 
control cells are depicted. HU treatment raised the cellular superoxide levels to the same level as for 
the positive control cells treated with hydrogen peroxide (1.7 fold increase). 
A further experiment done with STA-NB-10 cell line to provide information about the superoxide 
levels in the first two weeks of HU treatment (150µM) is shown in Figure 21. The relative 
fluorescence intensities measured by FACS are depicted. As expected, HU increased the superoxide 
levels markedly after 5 days (3.4 fold) and another increase was observed after 15 days (7.3 fold). 
Highest superoxide levels were observed in STA-NB-10 cells treated for 8 weeks with HU (13 
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fold). 
Figure 21. Increase in 
superoxide with time 
after induction of STA-
NB-10 cells. STA-NB-
10 cell line was induced 
with 150µM HU for 1 to 
56 days. Speroxide was 
measured by MitoSox 
fluorescence intensity 
measured by FACS and 
is depicted as relative 
values to untreated 
control cells.  
 
4.3.2 Change in Peroxide Levels and Derivatives  
To measure the levels of peroxide and its derivatives (Figure 22), 75 µM HU treated (induced), 
induced senescent and control STA-NB-9 (untreated) populations were stained with DHR. Details 
about treatment of cells and staining method are described in chapter 2.1.5 and 2.3.4. In Figure 22A 
induced cells show a 2.4 fold increase of peroxide and derivative levels. Induced senescent cells 
increase 6.9 fold compared to untreated cells. Results are relative values to the untreated control 
cells and the standard errors of 5 different experiments are shown. The asterisk indicates a 
significant difference compared to the control (p < 0.05). Relative fluorescence intensity of 
untreated cells is comparable to the intensity measured in MRC5 fibroblasts. In Figure 22B slide 
grown live STA-NB-9 cells were imaged by confocal light imaging. Typical cells of untreated 
control cells were taken with a magnifying objective of 63x while the images of the typical induced 
and induced senescent cells were taken at 40x. Untreated cells show a small cytoplasm and neuronal 
outgrowth. These cells show little DHR fluorescence (green). In HU treated cells the fluorescence 
intensity is faint but increases compared to the control cells. Moreover, the cells get flatter and 
larger. Induced senescent cells show the enlarged, flattened morphology. Bright fluorescent staining 
is localized in the cytoplasm at the mitochondria, leaving the nucleus unstained. 
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Figure 22. Increase in peroxide and peroxynitrite levels. A Relative fluorescence intensity of oxidized 
DHR in untreated (relative fluorescence intensity of 1), HU induced (induced), HU induced senescent 
(induced senescent) STA-NB-9 cells and MRC5 fibroblasts was measured by FACS. Asterisk indicates 
significance p<0.05. B Fluorescence and phase contrast images of untreated, induced and induced senescent 
cells are depicted. 
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4.3.3 Change in Mitochondrial Mass and Mitochondrial Membrane Potential 
To measure mitochondrial mass (Figure 23A) 75 µM HU treated, induced senescent and control 
STA-NB-9 cells were stained with the cardiolipin binding dye NAO and samples were analysed by 
FACS. Results are relative values to the untreated control cells and the standard errors of 3 different 
experiments are shown. HU treated and induced senescent cells showed an increase in 
mitochondrial cardiolipin bound NAO. The MFI of the HU treated cells increases 1.4 times while 
senescent cells increased 3.4 times compared to control cells. Results are not significant (p > 0.05) 
still an increase in relative fluorescence intensity could be observed in all three experiments. 
To measure mitochondrial membrane potential ∆ψm (Figure 23B) 75 µM HU treated, HU induced 
senescent and control STA-NB-9 cells were stained with JC-1 and were analysed by FACS. Results 
are shown as ratios of the 530 nm (FL1) and 670 nm (FL3) intensity and are relative values to the 
untreated control cells. The standard errors of 3 different experiments are shown. HU treated and 
induced senescent cells showed a decrease in ∆ψm. The relative fluorescence intensity of HU 
treated cells decreases to 0.5 compared to untreated cells with the relative ratio value of 1 and 
induced senescent cells show a ratio of 0.6. 
 
Figure 23. Increase in mitochondrial mass 
and decrease in mitochondrial membrane 
potential ∆Ψm. Mitochondrial mass A is 
measured by FACS as intensity of NAO and 
is here depicted as relative value to the 
untreated cells. ∆Ψm B is depicted as 
relative ratio of green (FL3) to red (FL1) 
fluorescence compared to the control ratio. 
The standard errors of 3 different 
experiments are shown.  
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4.4 Lamin and Associated Proteins 
Changes of lamins and lamin associated proteins were found to correlate to normal aging and 
premature aging syndromes like Hutchinson Gilford progeria and other laminopathies. Therefore, it 
was assessed whether the HU induced senescent tumour cells showed changes in the composition 
and timely appearance of nuclear lamina. Moreover, we were interested to characterise the 
properties of the nuclear lamina of micronuclei that formed spontaneously and which were induced 
by HU treatment.  
In Figure 24 the composition of the lamina of neuroblastoma cells is depicted. Only a small 
proportion of cells showed lamin A/C staining (Figure 24A), whereas a high percentage of cells 
showed incorporation of lamin B (Figure 24B) into the nuclear lamina. Mitotic cells indicated by 
arrows showed association of chromatin (DAPI) with lamin A/C but not with lamin B. Cells with 
incorporation of lamin A/C often showed lobulated nuclei resembling cells from progeria patients 
(not shown).  
 
Figure 24 Lamin expression on untreated neuroblastoma cells. Untreated STA-NB-10 cells were stained 
with α-lamin A/C antibody A or with α-lamin B antibody B and as secondary antibody a TRITC labelled 
antibody was used. In the left row the DAPI channel is shown in blue. The middle row shows the specific 
lamin staining in red and the right row shows the merged channels. The images were taken with a 40x 
objective. Mitotic cells are indicated by arrows. 
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Figure 25. Untreated STA-NB-10 cell population show only rare cells with incorporation of lamin A/C 
into the nuclear membrane. In the first column DAPI staining a), in the second column lamin A/C b) is 
shown. The third column shows the merged channels c). Images were taken with a Zeiss Axioplan 2 with the 
63x objective. Arrows indicate cells with faint positive lamin A/C staining. 
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The different types of lamin A/C staining found to occur in STA-NB-10 cells are shown in Figure 
25. One type of staining found showed lamin A/C incorporation preferentially at the poles of the 
nuclei (Figure 25A). Double staining with lamin B revealed that these lamin A/C positive poles  
show no or weak lamin B staining (data not shown). In Figure 25B a cell with a defined, structure-
giving accumulation of lamin A/C is shown. This concretion of lamin A/C coincides with a high 
intensity in DAPI staining. At sites of micronuclear budding cells showed similar structure-giving 
lamin A/C accumulation (data not shown). In Figure 25C a lobulated nucleus is shown with high 
lamin A/C intensity at the site of the nuclear membrane and at distinct intranuclear foci. Figure 25D 
shows the differences in intensities of lamin A/C at the site of the nuclear lamina. The weaker 
stained cell shows additional intranuclear diffuse staining.  
To further assess the composition of the nuclear envelope of neuroblastoma cells the untreated 
STA-NB-10 cells were stained with a prelamin A antibody recognising the C-terminal tail of 
uncleaved lamin A (Figure 26A). Further, lamin A/C binding protein LAP2α which is involved in 
cell cycle regulation was stained (Figure 26B). Nuclear pore complexes were assessed by staining 
with a monoclonal mAb414 antibody raised against a conserved domain in nucleoporins (Figure 
26C). The staining of prelamin A in Figure 26A was found in the nucleus and in the cytoplasm, but 
not incorporated at the site of the nuclear envelope. The intranuclear staining concentrates to the 
centres of the nuclei, omitting the outer nuclear regions. Mitotic cells showed cytoplasmic staining. 
Figure 26B shows that LAP2α is localized in the nucleus. There it forms a pattern that omits 
regions of the nucleus and accumulates in other regions. Moreover, TRITC intensity is 
heterogeneous in untreated cells. In mitotic cells LAP2α appears around the condensed DNA. In 
Figure 26C nuclear pore complexes are found preferentially at the site of the nuclear envelope but 
also intranuclear patches occurred. Mitotic cells showed nuclear pore staining surrounding the 
nucleus. Spontaneous F-cells with enlarged cytoplasm also showed cytoplasmic staining.  
As there was a high heterogeneity found for different lamin stainings and associated proteins in the 
untreated cells, double staining was performed. To discriminate for spontaneous senescent F-cells, 
the untreated population was stained for CD44, a surface marker not expressed on N-cells.  
CD44 positive cells in general showed lamin A/C staining and lower lamin B intensity. For double 
staining with antibodies against the nuclear pore complex and CD44, there was no significant 
difference in fluorescence intensity observed. There was, however, an increased amount of nuclear 
pore staining in the cytoplasm of the CD44 positive cells (not shown). In Figure 27 double staining 
for CD44 and prelamin A is shown. In Figure 27 the line profiles show that the intensity of 
prelamin A in N-cells is only 30% of total intensity found in the image. In the spontaneous 
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senescent cell intensities reach from around 55% intensity in the cytoplasm to around 80% in the 
nucleus. The cytoplasm is encircled by CD44 positive staining marking the membrane bound 
surface molecule. In the cytoplasm, moreover a micronucleus, indicated by the arrow, shows 
weaker DAPI staining (55%), around 75% TRITC-prelamin A intensity and 20% FITC-CD44 
intensity. 
 
Figure 26 Lamin and associated proteins in STA-NB-10 cells. In a) DAPI staining (blue) is shown, in b) 
the TRITC conjugated secondary antibody staining (red) and in c) the merged channels are shown. Images of 
cells stained for prelamin A (A), LAP2α (B) and nuclear pore complex (C) are shown. Mitotic cells are 
indicated by arrows, spontaneous F-cell is indicated by asterisk.  
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Figure 27 Accumulation of prelamin A in spontaneous senescent cells. A Untreated STA-NB-10 cells 
were stained for a) DAPI (blue), b) prelamin A (red) and c) CD44 (green). The arrows indicate a 
micronucleus. Merged channels are shown in d). The line traces in white of the CD44 positive cell i) and of 
the CD44 negative cell ii) correspond to the profiles in B. In B the profile of the two cells shown in Ad) are 
depicted. x-axis indicates the distance of the white line, whereas the y-axis corresponds to the fluorescence 
intensity. The arrow in Bi) indicates the site of the micronucleus.  
In Figure 28 double staining for CD44 and LAP2α is shown. In Figure 28A the line profiles show 
that the intensity of LAP2α in N-cells reached from 50% to 100% of total intensity found in the 
image. In the F-cells intensities reach a maximum in the nucleus of 40% of total intensity. In the 
profile of N-cells (Figure 28Bi) a negative correlation of heterochromatic, DAPI intensive areas and 
LAP2α was observed. At position 265 of the line trace nuclear DAPI intensity of this cell was at its 
peak while nuclear LAP2α reaches its minimum nuclear intensity.  
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Figure 28 Reduced LAP2α in spontaneous senescent cells. A Untreated STA-NB-10 cells were stained for 
a) DAPI (blue), b) LAP2α (red) and c) CD44 (green). Merged channels are shown in d). The line traces in 
white of the CD44 positive cell i) and of the CD44 negative cell ii) correspond to the profiles in B. In B the 
profile of the two cells shown in Ad) are depicted. x-axis indicates the distance of the white line, whereas the 
y-axis corresponds to the fluorescence intensity. The arrow in Bi) indicates the site of high DAPI staining. 
In a further experiment the correlation between lamin expression and MYCN status of 
neuroblastoma cells was assessed. Therefore, untreated cells were stained for lamin A/C or lamin B. 
Following fixation, indirect FISH was done with a BAC clone hybridizing to the MYCN gene. In 
Figure 29 examples of lamin B stained cells (Figure 29A) and lamin A/C stained cells (Figure 29B) 
are given. Cells with only a low MYCN copy number show similar lamin B fluorescence intensities 
as compared to amplified nuclei. Moreover, the majority of MYCN containing micronuclei 
(indicated with arrow) showed lamin B staining. In Figure 29B images of lamin A/C stained cells 
are depicted. The intensity of lamin A/C staining is considerably high, which is the reason for the 
faint nuclear envelope staining shown in the FITC channel (bleed through). These cells show no 
excess number of MYCN copies and lamin A/C staining. Moreover, cells showing high 
amplification of the oncogene do no express lamin A/C.  
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In order to evaluate the effect of HU on the lamin composition in the nuclear lamina, a time course 
experiment was carried out treating STA-NB-10 cells with 150µM HU for 10 weeks. In Figure 30 
the change in lamin A/C and lamin B incorporation into the nuclear lamina and change in nuclear 
morphology is depicted in untreated cells (Figure 30A), 5 days treated cells (Figure 30B) and 70 
days treated cells (Figure 30C). Only a small proportion of cells showed lamin A/C positive 
staining, whereas all cells incorporated lamin B into the nuclear lamina. After 5 days of HU 
treatment, a higher amount of destroyed cells were found on the slides. Moreover, the nuclear area 
of intact cells enlarged. The small fraction of cells which were positive for lamin A/C showed a 
Figure 29 Interphase MYCN FISH 
on lamin stained untreated STA-
NB-10 cells. Images of cytospin 
preparations were stained for a)
DAPI (blue) and Ab) lamin B (red) 
or Bb) lamin A/C. An indirect FISH 
was performed with a MYCN probe 
(green) c) to show the amplified 
MYCN copies. In d) the merged 
channels are shown. Micronuclei 
are indicated by the white arrows. 
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reduced staining intensity in lamin B. After 70 days of treatment with HU a large part of the 
population showed increased cellular and nuclear areas. An increased part of the population showed 
lamin B replaced by lamin A/C at the nuclear envelope. Moreover lamin A/C positive cells showed 
lobulations and invaginations of the nuclear lamina. 
 
Figure 30 Increasing lamin A/C positive population and morphology change along with HU treatment. 
Images of untreated STA-NB-10 cells A were compared to cells induced with HU for 5 days B or 70 days C. 
Cytopreparations were stained for lamin A/C in green a) and for lamin B in red b), DNA was stained with 
DAPI c). The merged channel is shown in d). Images were taken with a Zeiss Axioplan microscope with a 
40x lens. 
To quantitate the amount of lamin A/C positive cells at least 300 cells were counted per time point. 
The result is shown in Figure 31. A drastic increase in lamin A/C positive cells in the late time 
points of HU induction can be observed. Only 1.1% of the populations of time points 0 (untreated 
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cells) to 15 days of HU treatment were positive for lamin A/C. However, 67% of the cell population 
incorporated lamin A/C into the nuclear lamina after 8 weeks treatment (56 days). Surprisingly, of 
the population induced for 10 weeks 58% of the cells were lamin A/C positive whereas in another 
parallel population treated one day longer with HU 28% of the population was stained positive for 
lamin A/C.  
 
Figure 31 Increase in lamin A/C positive cells with HU induction. In the graph the percentage of lamin 
A/C positive cells are depicted per time point of HU induction. A minimum of 300 cells were analysed for 
positive lamin A/C staining per time point by counting with a Zeiss Axioplan microscope with a 40x lens. 
To further investigate the composition of the nuclear lamina after 10 weeks treatment with HU, line 
trace profiles of lamin A/C positive cells were assessed. In Figure 32 a line trace profile through a 
lobulated nucleus is shown (white line). This cell pinches a micronucleus from the main nucleus 
off. Moreover, DAPI staining (a) shows differences in DNA density. Lamin B fluorescence 
intensity (b) is low, whereas lamin A/C intensity is high (c). The merged channels are depicted in 
(d). In Figure 32B the fluorescence profile along the white line is shown. Lamin B incorporation at 
the micronucleus is lower than 10% whereas the maximal intensity in the nucleus is 50%. Lamin 
A/C intensity correlates with DAPI intensity showing high percentage of intensity at the nuclear 
periphery and low intensity at the centre of the nuclei. Moreover, the lobulations are highly lamin 
A/C positive reaching 100% intensity. 
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Figure 32 Profile of lobulated 10 weeks HU induced STA-NB-10 cell. A Cytospin preparations were 
stained for a) DNA with DAPI (blue), b) lamin B (red) and c) lamin A/C (green). Merged channels are 
shown in d). The white line trace in A indicates the profile depicted in B. In B the profile of the lobulated 
cell is shown. The x-axis indicates the distance of the white line, whereas the y-axis corresponds to the 
fluorescence intensity of the different channels.  
4.5 Analysis of the Senescence Pathway 
From the time course experiment performed with HU induced STA-NB-10 cell populations, 
explained in detail in chapter 2.1.3, protein levels were analysed. In Figure 33 total protein lysates 
were prepared and probed for MYCN levels. Moreover, CDKIs (p21, p16) involved in the 
senescence pathway and their upstream and downstream interacting partners (p53, pRb) described 
in detail in chapter 1.2.3 were blotted. 
MYCN, as product of the corresponding amplified gene in STA-NB-10 neuroblastoma cells 
decreases time dependent. After 56 days (8w) protein levels are negligible. Levels of tumour 
suppressor protein p53, which is a key regulator of genome integrity increase after 5 days (5d). The 
amount of p53 in cells after 56 days is again found decreased to a level comparable to untreated 
cells (0d). Additionally, with induction of p53, the levels of p21 - the downstream target of p53 - is 
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changed. p21 persists at high level after 56 days compared to untreated cells. p16 levels decrease 
until day 10 and afterwards increase again. p16 levels after 8 weeks are still lower than in untreated 
cells. pRb levels stay unchanged in the first three time points, whereas they decline slightly at day 
10 and stay reduced. The blot for pRb showed at maximum four bands, where the uppermost is only 
present after 5 days. After 8 weeks only the lowest band shows strong signals. As loading control a 
ponceau staining was done and integrated density was measured by Image J, which is depicted in 
the lowest row. The loading of the different protein samples changes slightly. Highest loading 
differences are observed in protein samples of day 5 (1.2 fold the protein level of untreated cells) 
and day 10 (0.8 fold). 
 
Figure 33 Senescent pathway analysis by Western blot. STA-NB-10 cells were HU induced and proteins 
were collected after 0 (0d), 1 (1d), 5 (5d), 10 (10d), 15 (15d) and after 56 days (8w). Totalprotein lysates 
were blotted and probed for MYCN, p53, cyclin dependent kinase inhibitor 1A (p21), cyclin dependent 
kinase inhibitor 2A (p16) and retinoblastoma protein (pRb). Ponceau staining was taken as loading control 
and integrated density measurements (IDM) is depicted as relative values to the STA-NB-10 untreated 
control lane (0d loading control). 
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5 Discussion 
5.1 Markers of Senescence: Cell Morphology and SA-β-Gal Activity 
Neuroblastoma cells are documented to show different types of cells: N-cells show a scant 
cytoplasm and high MYCN copy number. F-cells, occurring spontaneously show a flat morphology 
and SA-β-Gal activity (Ambros and Ambros 2000; Narath, Ambros et al. 2007). Time dependent, 
the amount of SA-β-Gal expressing neuroblastoma cells increased. These cells showed typical 
morphology of senescent cells with large, flat and granular cytoplasms. The population after 8 
weeks of continuous HU treatment consisted primarily of senescent cells. The proportion of cells in 
G1-phase increased, while the proportion of cells in G2/M-and S-phase decreased. Dimri et al. 
showed that senescent fibroblasts and keratinocytes were positive for SA-β-Gal. Quiescent, 
presenescent or differentiated cells were negative for this enzyme (Dimri, Lee et al. 1995). In 
fibroblasts (REF52 and HFF) HU could induce proliferation arrest (Marusyk, Wheeler et al. 2007) 
and senescence (Yeo, Hwang et al. 2000). Human erythroleukemia K562 cells and rat heptoma cells 
got senescent and showed G1 arrest but neither differentiation nor programmed cell death was 
induced (Park, Jeong et al. 2000; Hong, Hong et al. 2004). In a previous study SA-β-Gal positive 
HU treated neuroblastoma cells showed decreased telomerase activity and shortened telomeres 
(Narath, Ambros et al. 2007). This lead to the assumption that long term low dose HU treatment of 
MNA neuroblastoma cells induces senescence which is marked by a flat morphology and SA-β-Gal 
activity.  
With HU treatment not only senescent cells but also cells with neuronal features of differentiation 
appeared. HU is known to induce differentiation in erythroid precursor cells (Rencricca, Morse et 
al. 1975; Nagai, Tarumoto et al. 2003) and in erythroleukemias (Park, Choi et al. 2001), but in 
neuroblastoma cells usually retinoic acid is used for induction of differentiation. Interestingly, 
MYCN was shown to block terminal differentiation in retinoic acid induced MNA neuroblastoma 
cells (Thiele, Reynolds et al. 1985). Thus the reduced MYCN copy number, as well as its reduced 
expression and changes in the cell cycle machinery indicated by changes in CDKI levels (Figure 
33) and cell cycle profile might be the cause for differentiation of a part of the population after HU 
treatment. 
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5.2 Proliferation, Growth and Cell Cycle Assay, MYCN Copy Number 
5.2.1 HU Induced S-phase Arrest followed G1-arrest and Decline in Cell 
Population 
Cell cycle analysis of untreated MNA neuroblastoma cells revealed a mean S-phase population of 
27% while G1-phase accounted for 68% and G2/M population accounted for 5% (STA-NB-9 and 
STA-NB-10). This high amount of cells in S-phase of nearly 30% marks the highly proliferative 
character of the primary tumours from which the cell lines were generated. With HU treatment, up 
to 50% of the induced STA-NB-10 cells were found in S-phase of the cell cycle. There was a 
difference in the onset of the increase in S-phase in between the short term experiment lasting 10 
days and the long term experiment lasting more than 8 weeks. S-phase increase peaked in the long 
term HU treatment after 5 days, with 42%, while in short term treatment increased S-phase was 
seen faster, after 1 day. Probably the experimental system of the two experiments, T25 flasks in the 
long-term treatment, 6-well plates in short term treatment, lead to this difference. Still, not the exact 
time point of S-phase increase, but information about the order of changes after induction was of 
our interest. Simultaneously to S-phase increase, the G1 population decreases and only in STA-NB-
9 the G2/M population declines. This could account for either increased proliferation of cells or for 
arrest of cells in S-phase. The experiment measuring proliferation by BrdU incorporation over 24 
hours elucidates this. As untreated and induced cells show the same amount of cells proliferating, 
the increase in the population in S-phase of the cell cycle profile must account for S-phase arrest. 
This is underlined by the fact that HU is known to deplete for dNTPs by blocking RRM, thus 
elongating the time needed for DNA replication (Schrell, Rittig et al. 1997; Szekeres, Fritzer-
Szekeres et al. 1997). Together, this suggests that S-phase blockage occurs shortly after HU 
treatment. 
Interestingly, after the population peaks in S-phase, a marked reduction of this population was 
observed, which is accompanied by increase of the G1-population. Moreover, a part of the cells 
treated with HU died continuously as indicated by the growth curve. This decrease in cell number 
could account for apoptosis of a part of the population. Also meningiomas (Schrell, Rittig et al. 
1997) and melanomas (Krämer, Knauer et al. 2008) were found to undergo apoptosis after HU 
treatment, although drug doses were an order of magnitude higher compared to our study. Still, also 
low dose HU treatment leads to an increase in apoptosis as shown in COLO320 cells (Petit, 
Davidson et al. 1999). In studies with neuroblastoma cells members of the TNFR family (p75 and 
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CD95) and Bcl-2 were found to induce apoptosis (Dole, Nunez et al. 1994; Bunone, Mariotti et al. 
1997; Fulda, Sieverts et al. 1997). Whether these genes are involved in HU mediated apoptosis or 
whether another cell death causing program (nekrosis, anoikis) is induced by HU in neuroblastoma 
cells has still to be elucidated. 
Different effects of HU treatment may be dependent on the cell cycle phase of the individual cell of 
the asynchronous population. It was shown that HU depletes for dNTPs by blocking ribonucleotide 
reductase. dNTPs are necessary for replicating DNA and thus passing S-phase. Therefore S-phase 
arrest is suggested to occur by treatment with HU (Schrell, Rittig et al. 1997; Szekeres, Fritzer-
Szekeres et al. 1997). This was approved here after 1-5 days low dose HU treatment. Moreover, HU 
is thought to induce replication fork stallings that lead to increased DNA damage (Ward and Chen 
2001; Marusyk, Wheeler et al. 2007). The guardian of the genome, p53 is a key protein involved in 
the DDR. Here we could show an induction of p53 and its downstream target p21 after 5 days of 
treatment which would indicate a DDR induced by HU in MNA neuroblastoma cells. When an 
asynchronous population is thus treated with HU, primarily the cells in S-phase are impaired, which 
could account for a heterogeneity of the whole population.  
 
5.2.2 HU Induced Loss of MYCN Copies in MNA Neuroblastoma Cells 
Neuroblastoma cells which have an amplification of the transcription factor MYCN show aggressive 
growth characteristics and patients with this kind of tumour have a poor survival expectation 
(Nakagawara, Arima et al. 1992; Brodeur 2003). Low dose HU treatment accelerates the expulsion 
of amplified genes in the form of dmin from neoplastic cells in vitro (Snapka and Varshavsky 1983; 
Benner, Wahl et al. 1991; Von Hoff, Waddelow et al. 1991; Christen, Shalinsky et al. 1992; Von 
Hoff, McGill et al. 1992; Canute, Longo et al. 1996; Narath, Ambros et al. 2007) and in vivo 
(Raymond, Faivre et al. 2001). These dmin chromosomes were shown to be expulsed into 
micronuclei in cell lines (Von Hoff, McGill et al. 1992; Shimizu, Kanda et al. 1996; Narath, 
Ambros et al. 2007) and in primary neuroblastoma (Freeman-Edward, O'Neill et al. 2000; Valent, 
Benard et al. 2001). Here we show that the amplified MYCN gene is present in neuroblastoma cells 
STA-NB-9 and STA-NB-10 in the form of dmin. Additionally, we could show a time related loss of 
amplified MYCN copies during low dose HU treatment in MNA cell lines. The number of amplified 
cells is lower after 1 day, 10 days and 70 days of treatment compared to the untreated cells. Still, 
fewer non-amplified cells were found in the 10 days induced population than in the 70 days 
population. This increase in MYCN copies could account for different confluences of the starting 
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populations of each time point (flask) All flasks contained subconfluent cell populations but to 
different degrees which may be associated with differences in HU effectiveness. Moreover, with 
treatment the proportion of different cell types (N- and F-cells) varied. In the 70 days induced 
population, the flask contained more cells with differentiating phenotype than in the flask 
containing the 56-day induced population of the cell lines analysed.  
The mechanisms by which dmin are expulsed are not yet known. However, dmin were shown to 
localize to the periphery of the nucleus (Freeman-Edward, O'Neill et al. 2000) and associate with 
lamins during S-phase (Tanaka and Shimizu 2000). Interestingly, we found amplified MYCN copies 
to localize preferentially to peripheral sites of the nucleus in the asynchronous cell populations.  
Lamin B was found preferentially at sites of the nuclear lamina but also intranuclear association of 
signals occurred. The localisation of lamin B to dmin in certain cells might indicate that these cells 
are in S-phase of the cell cycle. For the first time we could show that lamin A/C was only expressed 
in neuroblastomas which show no MYCN amplification.  
Treatment with HU accelerated expulsion of amplified extrachromosomal genes into micronuclei 
(Narath, Ambros et al. 2007). Additionally, HU induces premature senescence in several tumour 
cells (Park, Jeong et al. 2000; Hong, Hong et al. 2004; Kwak, Kim et al. 2004). Interestingly, also 
cells from patients with premature aging syndrome (Werner disease, Cockayne syndrome, Ataxia 
telangiectasia and Down syndrome) show an elevated formation of micronuclei (Weirich-
Schwaiger, Weirich et al. 1994). In neuroblastoma cells treated with HU we found premature 
senescence to occur with the formation of micronuclei packed with MYCN (data not shown). 
Ultrastructural studies showed that micronuclei are surrounded by a double membrane with nuclear 
pores like normal nuclei (Gernand, Rutten et al. 2005). Not all micronuclei were found to be 
surrounded by a nuclear lamina, but the ones which did, were associated with the same lamina 
proteins as the nuclei from which they originated. These indications are solely descriptive and 
cannot account for conclusions about the formation of micronuclei during HU treatment.  
Interestingly, during S-phase dmin were suggested to be selectively expulsed by budding (Itoh and 
Shimizu 1998; Shimizu, Itoh et al. 1998; Tanaka and Shimizu 2000). Thus, a correlation between 
the found S-phase propagation delay and selective expulsion of micronuclei might give a hint about 
the mechanism of HU as a micronuclei inducing substance. 
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5.3 Investigation of ROS Involving Mitochondrial Function in 
Neuroblastoma Cells Undergoing a Senescent Phenotype after HU 
Treatment 
Mechanisms involving ROS were suggested to promote a senescence phenotype (chapter 1.2.2.4). 
Already in the 1950 Harman postulated that free radicals which were encountered throughout life 
damage cells by oxidation of cellular components. In turn cellular functions are impaired and the 
damaged cell starts senescing (Harman 1956). Reactive species, like ROS and RNS can have 
endogenous origin prevalently generated by leaking mitochondria or they are introduced into the 
cell by various environmental influences (IR, UV, cytokines, growth factors, chemotherapeutic 
drugs, and environmental toxins). Next to protein aggregation and lipid peroxidation which 
inactivates the function of these cellular building blocks, DNA as carrier of genetic information is 
damaged.  
We hypothesized that HU induced cells show high amounts of cellular ROS which leads to a 
positive feed-back-loop involved in the onset of senescence. Therefore, the levels of ROS of 
neoplastic MNA neuroblastomas derived from aggressive primary tumours were assessed. 
Moreover, the timely correlation between ROS and senescence markers were monitored.  
Recently new methods of measuring ROS were established. MitoSOX Red, a mitochondrial 
superoxide indicator, is targeted to the mitochondria and selectively oxidized by superoxide. Its 
fluorescence intensity is determined by live cell imaging using a fluorescence microscope or by 
flow cytometric analysis. The amount of mean fluorescence intensity in the mitochondria is 
correlated to the cellular superoxide status. It was shown not to be oxidized by other ROS- or RNS-
generating systems and scavenging proteins like superoxide dismutase prevents oxidation of the 
dye. (Nieminen, Byrne et al. 1997; Maurer, Metelitsa et al. 1999; Konorev, Zhang et al. 2000; 
Melov 2000; Hardman, Afshari et al. 2001; Mawatari and Murakami 2001; Takahashi, Shibata et al. 
2001; Batandier, Fontaine et al. 2002; Diaz, Liu et al. 2003; Scotti, Iamele et al. 2003). 
In HU-induced MNA-NB cells changes in mitochondrial superoxide levels were observed. In STA-
NB-9 cells the mitochondrial superoxide levels increase with HU induction already after 24 hours 
induction 1.7 fold. Moreover, treatment for 24 hours of MNA-NB cells with hydrogen peroxide, a 
ROS itself, mimics the effects of increased oxidative stress. Superoxide levels augment 1.7 fold, 
which equals the increase of superoxide of cells treated with HU. Moreover, untreated low passage 
MRC5 fibroblasts showed comparable levels of superoxide as untreated MNA neuroblastoma cells.  
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STA-NB-10 cells were less prone for oxidative stress, as they show lower amounts of mitochondrial 
superoxide level after 24 hours (1.2 fold) than STA-NB-9 cells. Moreover, with induction 
superoxide levels augment gradually to a final 13-fold increase compared to the untreated 
population. In comparison to the 13-fold increase found in senescent STA-NB-10 cells, the final 2.7 
fold increase measured by flow cytometry in senescent STA-NB-9 cells seems low. Still, in the 
microscope, STA-NB-9 cells seem to increase more than the FACS measured value. Moreover, cell 
debris and dead cells were stained highly in STA-NB-9 cells which could raise basal levels of 
untreated cells and thus reduce the difference between control and senescent cells. From a 
biological point of view, the difference between the senescent STA-NB-9 cells and the senescent 
STA-NB-10 cells might be the used cultivation medium. STA-NB-9 cells were grown in HU-free 
medium, while STA-NB-10 cells were treated still with HU. 
Measurements of cellular peroxide and peroxynitrite levels can be achieved by Dihydrorhodamine 
123 (DHR) staining. This dye is oxidized by H2O2 and organic peroxides in the presence of 
catalysts like catalase and peroxidase, by peroxynitrite, by pyocyanin and phenazine methosulfate. 
NO or superoxide alone, the substances that in combination form peroxinitrite cannot oxidize DHR. 
Moreover, DHR is a an efficient singlet oxygen generator upon illumination and in cellular systems 
it produces singlet oxygen in mitochondria where it accumulates and induces oxidation of 
NAD(P)H (Briviba, Roussyn et al. 1996; Crow 1997; Sies, Sharov et al. 1997). HU treated STA-
NB-9 MNA-NB cells show significantly increased levels of peroxide and its derivatives. Moreover, 
the levels of oxidized fluorescent DHR in untreated MNA neuroblastoma cells is comparable to low 
passage MRC5 fibroblasts. Thus, we could verify that with HU induction and with HU-linked 
senescence, the levels of cellular peroxide and derivatives increase. 
The above mentioned leads us to the suggestion that HU may also be an inducer of oxidative stress, 
like H2O2. A study reported that in non-MNA neuroblastoma cell line SH-SY5Y cellular death was 
enhanced when treated with H2O2 (Castino, Bellio et al. 2007). Also in this study we see a high 
proportion of cells dying after induction with H2O2. Treatment with HU for 10 days also decimates 
the cell number of STA-NB-10 cells to half the starting population. Similar, induction of ROS in 
several MYCN amplified neuroblastoma cell lines leads to apoptosis by induction of PKC-
δ (Domenicotti, Marengo et al. 2003; Marengo, Raffaghello et al. 2005; Ferretti, Marengo et al. 
2007; Marengo, Balbis et al. 2008; Marengo, De Ciucis et al. 2008). Thus we suggest that low dose 
HU treatment increases cellular ROS levels which might be the reason for increased decline in cell 
population over time. The remaining cells might have a different redox-potential or a blocked 
apoptotic pathway which then triggers senescence.  
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10-N-nonyl acridine orange (NAO) is a dye that is incorporated into mitochondrial membrane 
protein cardiolipin. Its uptake is independent of transmembrane mitochondrial potential and it is an 
indicator for mitochondrial membrane mass (Leprat, Ratinaud et al. 1990; Oubrahim, Stadtman et 
al. 2001; Passos, Saretzki et al. 2007). HU induced MNA neuroblastoma cells which are 
presenescent, show slightly increased mitochondrial cardiolipin incorporation. However, induced 
senescent cells show a 3.4-fold increase in mitochondrial mass. This suggests that the amount or the 
size of mitochondria increases. As an increase in size of mitochondria was also seen in images of 
HU induced senescent MNA neuroblastoma cells taken with the electron microscope (not shown) 
we suggest that with ongoing senescence and HU treatment, mitochondria increase in size. 
JC-1 is a lipophilic fluorescent cation that is selectively targeted to mitochondria and changes its 
fluorescence reversibly at different membrane potentials. This is achieved as the dye aggregates 
upon high membrane potential and emits a bright red-orange fluorescence at 590 nm. At low 
membrane potential, JC-1 is present in monomeric form and emits green fluorescence. The 
measured ratio determines mitochondrial membrane potential ∆ψm and thus is an indirect measure 
of the functionality of the mitochondrial membrane (Di Lisa, Blank et al. 1995; Salvioli, Ardizzoni 
et al. 1997; Passos, Saretzki et al. 2007). In MNA neuroblastoma cells induced with HU membrane 
potential decreases to half of the starting value. ∆ψm is again increased slightly when induced 
senescent cells are released into HU free medium. This might indicate that HU is involved in 
lowering the membrane potential and thus inducing dysfunctional mitochondria. In our experiments 
we could see a gradual, quick increase in ROS levels after HU treatment. It is known that oxidative 
stress damages primarily mtDNA which is essential for proper mitochondrial function. 
Consequently, dNTPS are essential for maintenance and repair of mtDNA damage. Ribonucleotide 
reductase small subunits RRM2 and p53 inducible RRM2B need iron molecules in order to convert 
NTPs into dNTPS (Terman and Brunk 2006; Voss and Siems 2006). HU is an iron chelator and is 
known to inactivate these rate limiting enzymes (Le and Richardson 2002; Lin, Belcourt et al. 
2007). Moreover, reduced mtDNA copy numbers were observed in patients with MDS (mtDNA 
depletion syndrome, OMIM 251880) who had deletions or mutations in the RRM2B gene. 
Depletion of dNTP for mtDNA synthesis and repair with low dose HU could pose a reason for 
decreased membrane potential and increased ROS production. This in turn reduces mitochondrial 
function which leads to a higher amount of released intermediate radicals from the oxidative 
phosphorylation process (Passos and von Zglinicki 2005). Thus, HU might not only induce 
increased ROS levels but also be directly involved in mtDNA depletion and further mitochondrial 
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impairment.  
Moreover, dysfunctional mitochondria lead to retrograde signaling, which raises the mitochondrial 
biogenesis leading to the generation of new functional mitochondria, which is also indicative for the 
increased mitochondrial mass we found in induced NB cells. 
Increased ROS is suggested to lead to oxidative damage of cellular components bringing about a 
DNA damage response. This is suggested to lead to age dependent increase in genetic instability 
(Halliwell 2007) but is also involved in premature senescence (Passos, Saretzki et al. 2007). 
In our model of tumor cell senescence, ROS increase may account for DNA damage. This 
suggestion is underlined, as p53 levels increased in early HU treated cells, which may account for a 
DNA damage response. This response may induce proliferation arrest and further ROS signaling 
may be the trigger for senescence. 
Several tumors were found to use the potential of ROS to induce proliferation (Halliwell 2007). 
Contrary, here the amount of ROS in neuroblastoma increases steadily with HU treatment and with 
increase in SA-β-Gal positive cells. Moreover, an increase in G1 population of cells is observed. 
These are all indicatives that in neuroblastoma cells ROS signaling does not account for increased 
proliferation and increased tumorigenic potential, but for opposite mechanisms: senescence is 
induced with reduced proliferation, changes in morphology, SA-β-gal positivity and as shown 
before, with shortened telomeres (Narath, Ambros et al. 2007). 
Moreover, NO - produced from HU - is a ROS itself and increases cellular oxidative stress (Wink 
and Mitchell 1998; King 2003; Pacher, Beckman et al. 2007). Moreover, NO was shown to act as 
important negative regulator of MYCN expression in neuroblastoma cells and it is suggested to 
negatively regulate proliferation by decreasing pRb phosphorylation (Ciani, Severi et al. 2004). In 
our experimental system the amount of MYCN expression decreases with HU treatment. Still, as 
only low doses of this substance are used, the amount of NO is assumed to be low. However, 
parallels can be seen in MYCN decrease and proliferation halt in HU treated NB cells. Thus 
perhaps different mechanism or the combined effects of superoxide, peroxide and NO induce 
MYCN downregulation and proliferation arrest.  
Here we could for the first time show that the mechanism underlying HU induced senescence might 
involve increased superoxide and peroxide levels. Moreover, mitochondrial membrane potential 
decreased and mitochondrial mass increased which indicates dysfunction of this organelle. In 
MRC5 fibroblasts a feedback loop is started by uncoupling of mitochondria, which further increases 
cellular ROS production (Passos, von Zglinicki et al. 2006).  
The connection between mitochondrial dysfunction and increased ROS in the onset of senescence 
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might involve telomere erosion (Passos and von Zglinicki 2005; Passos, Saretzki et al. 2007; 
Passos, Saretzki et al. 2007). In endothelial cells, mild chronic oxidative stress leads to loss of 
telomere integrity which is a major trigger for the onset of premature senescence (Kurz, Decary et 
al. 2004). In our experimental system shortened telomeres were shown after 6 weeks HU treatment 
(Narath, Ambros et al. 2007), which might indicate HU induced chronic oxidative stress to trigger 
premature senescence in MNA neuroblastoma cells. 
5.4 Lamin and Associated Proteins 
In normal individuals and also in mice, lamin A/C expression and incorporation into the lamina 
determines the state of differentiation. Lamin B is expressed in cells with a highly plastic potential, 
whereas lamin A/C is a marker of differentiation (Rober, Sauter et al. 1990). For the first time we 
observed an increase of lamin A/C expression in the induced senescent neuroblastoma cells which 
correlated negatively with lamin B expression. Coherent indications resulted from competitive 
microarray experiments done with STA-NB-9 and STA-NB-10, hybridizing cDNA from N-cells 
and HU induced senescent F-cells. There, LMNA was found to be expressed highly in F-cells while 
LMNB1 was found to be expressed in N-cells only. Several types of tumours including lymphomas, 
skin cancers and adenocarcinomas were found deficient for lamin A/C (Prokocimer, Margalit et al. 
2006). This suggests lamin A/C to have tumour suppressive functions (Nitta, Smith et al. 2007) as it 
keeps up a differential status with low plasticity. Here we could show for the first time that the N-
cells of the neuroblastoma cell lines STA-NB-9 and STA-NB-10 are deficient in lamin A/C. Long 
term low dose treatment with HU indicates differentiation and loss of plasticity of neuroblastic 
tumour cells STA-NB-9 and STA-NB-10 which might indicate tumour suppressive functions as 
shown by Nitta et al (Nitta, Smith et al. 2007). Lamin A/C was shown to increase markedly after 56 
days of HU induction. In cells treated for 70 or 71 days with HU, however, lamin A/C levels were 
lower again. This differences between the cell population treated for 56, 70 or 71 days might be 
caused because of high variations of different proportions of cell types present in the flasks of each 
time point. As different amounts of differentiated cells were present in the flask, this could make the 
high variation. 
Lamin B is expressed ubiquitously in mammalian cells. The expression of this cellular component 
is associated with cell growth and survival. In our senescence induction system a decline in lamin B 
expression was observed together with an increase in G1 arrested cells and induction of SA-β-Gal 
activity. This underlines the changes in differentiation and tumour cell revertance of neuroblastoma 
cells after HU treatment (Narath, Ambros et al. 2007). 
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Several lines of evidence suggest an involvement of lamin A in physiological aging processes. The 
connection of lamin A expression and aging arose when premature aging in the HGPS was 
correlated with a mutation in the LMNA gene introducing a cryptic splicing site. This leads to the 
accumulation of a truncated, farnesylated prelamin A - progerin- in cells from HGPS patients. The 
same phenomena could be observed to a smaller extent in cells from old organisms (Haithcock, 
Dayani et al. 2005; Lans and Hoeijmakers 2006; Scaffidi and Misteli 2006; Cao, Capell et al. 2007; 
Dechat, Shimi et al. 2007). 
In spontaneously occurring F-cells, which have comparable pheno- and genotype to induced 
senescencent neuroblastoma cells (Narath, Ambros et al. 2007), we could prove an increase in 
nuclear prelamin A. This together with the observed morphological changes, SA-β-Gal expression 
and strongly reduced proliferation activity suggests that cells from highly aggressive neuroblastoma 
are able to senesce prematurely.  
Misshaped nuclei with lobes and invaginations were found in cells from LMNA-/- mice 
(Lammerding and Lee 2005), in LMNA mutated fibroblasts from lipodystrophic patients 
(Vigouroux, Auclair et al. 2001) and from HGPS patients (Oberdoerffer and Sinclair 2007), in 
lamin deficient cells from Caenorhabditis elegans (Liu, Rolef Ben-Shahar et al. 2000) and in cells 
from aged C. elegans (Haithcock, Dayani et al. 2005). A change in the ultrastructure of the cells 
shown by misshaping of the nuclei was also found in the spontaneously occurring F-cells and in the 
HU induced premature senescent neuroblastoma cells. Lobulated nuclei were found to not only 
restricted to lamin A/C expressing cells, but also were found in lamin B expressing cells. Thus, 
lobulation may not be indicative for incorporation of mature lamin but for accumulation of 
prelamin.  These data suggest accumulation of prelamin A to account at least partially for the 
senescent phenotype in neuroblastoma cells.  
Already low concentrations of prelamin A accumulation lead to a change in heterochromatin, with 
facultative inactive regions becoming transcribed (Shumaker, Dechat et al. 2006). Usually, 
heterochromatic regions are structurally fixed and linked to the nuclear lamina. Cells from HGPS 
patients, but also late passage fibroblasts show less heterochromatic markers which suggests lamin 
A to be associated with the epigenetic control of heterochromatin. Moreover, HGPS as well as late 
passage cells show a loss of heterochromatin (Shumaker, Kuczmarski et al. 2003; Gruenbaum, 
Margalit et al. 2005; Scaffidi and Misteli 2006). On the other hand,  senescence-associated 
heterochromatic foci (SAHF), which consist of accumulated pRB proteins at sites of E2F 
promoters, are thought to lead to the irreversible proliferation arrest associated with senescence 
(Oberdoerffer and Sinclair 2007). This might suggest the involvement of prelamin A and lamin A/C 
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accumulation to indicate heterochromatic changes in HU treated neuroblastoma cells. A change in 
heterochromatic regions leads to changes in gene expression patterns as active chromatin gets 
silenced and vice versa. The high number of up- and down-regulated genes found in senescent 
neuroblastoma cells may indicate epigenetic regulation due to chromatin modifications to account 
for senescence: From 12982 genes analysed, 604 were upregulated and 786 were downregulated 
after 8 weeks of HU treatment. Still, further analysis investigating heterochromatic changes in 
induced senescent neuroblastoma cells and the involvement of lamins in this process have to be 
realised to give a clear answer. 
Another interesting feature of HGPS cells is that they cannot be immortalized, even when telomere 
length was stabilized and telomerase was activated (Wallis, Sheerin et al. 2004). Neuroblastoma cell 
lines STA-NB-9 and STA-NB-10 showed abrogated telomerase activity and telomeres shorten to 
50% of the previous length after 8 weeks of treatment with HU (Narath, Ambros et al. 2007). This 
phenomenon further points towards the possible importance of the nuclear lamina in tumour cell 
senescence of neuroblastoma cells.  
In concordance with high proliferative and aggressive behaviour of MNA neuroblastoma (Brodeur, 
Seeger et al. 1985; Brodeur 2003), also other lamin A deficient cells were shown to proliferate 
highly (Van Berlo, Voncken et al. 2005). Neuroblastoma cells show increased expression and 
protein levels of p16. This, however was not related to MYCN amplification, pRb phosphorylation 
status or G1/S phase arrest (Diccianni, Omura-Minamisawa et al. 1999). In this study we 
investigated proteins involved in the senescence pathway by western blotting and lamin A/C 
expression by IF in the same cell population treated with HU for 8 weeks. We found p16 to be 
present in lamin A/C deficient, untreated neuroblastoma cells. With ongoing treatment, p16 levels 
decreased until day 10 and finally increased again slightly. At this last time point more than 2/3 of 
the cell population show lamin A/C incorporated into the nuclear lamina. These cells have an 
increase in their G1-population indicating G1 arrest. Also p16 is present. Contrary to our results, 
cells depleted for lamin A/C failed to G1 arrest after induction of p16 (Nitta, Jameson et al. 2006). 
The number of lamin A/C expressing cells, however, was markedly increased only after long-term 
treatment. This suggests that p16 and lamin A/C expression are regulated independently and do not 
together implicate in G1 arrest.  
The protein connecting abrogation of growth and proliferation with loss of lamin A is suggested to 
be pRb. Hypophosphorylated, active pRb is an important factor involved in the senescence pathway 
(Itahana, Campisi et al. 2004). It binds E2F transcription factors which promote S-phase specific 
gene transcription when released from the complex. Moreover, pRb recruits chromatin remodelling 
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complexes to E2F specific gene promoters keeping them silenced and thus leading to G1 arrest of 
the cell cycle (Narita, Nuñez et al. 2003). In STA-NB-10 neuroblastoma cells HU treatment does 
not influence the pRb protein level markedly. On the other hand, early after HU induction cells 
accumulate in S-phase which might account for release of E2F-factors from the pRb complex which 
initiates S-phase specific gene transcription. Lamin A/C deficient cells showed high proliferative 
indices and could not be arrested in cell cycle (Nitta, Jameson et al. 2006). Untreated cells show 
high proliferation which increases at the beginning of treatment and further decreases. And lastly, 
LMNA-/- myoblasts showed impairment of fully differentiation. Combining these data with our data, 
a role for pRb has still to be investigated, as this is also one of the proteins involved in senescence 
pathways. Assuming no activity of pRb in lamin A/C deficient neuroblastoma cells, this could be 
the reason for unregulated proliferation, and thus a tumor promoting mechanism.  
Lap2α is a protein binding DNA via its LEM domain and it shows a diffuse nuclear staining. In 
cells from aggressive, MYCN amplified neuroblastoma it  seems to associate to DNA as DAPI 
staining and Lap2α staining resemble each other. Lamin A forms a complex with LAP2α and pRb 
which is supposed to retain hypophosphorylated pRb inside the nucleoplasm (Markiewicz, Dechat 
et al. 2002). In untreated neuroblastoma cells, in fact, lamin A is missing while a large amount of 
Lap2α is present in the cells.  
LAP2α deficient cells showed impaired cell cycle arrest and impaired differentiation(Dorner, Vlcek 
et al. 2006). This in turn was suggested to repress E2F transcriptional activation of S-phase genes 
and thus G1 arrest (Dorner, Vlcek et al. 2006). Moreover, the spontaneous senescent cells were 
found deficient for LAP2α. This coheres with the effect that LAP2α siRNA depletion in HDFs 
leads to arrest in G1-phase of the cell cycle (Pekovic, Harborth et al. 2007). Moreover, cells from 
old individuals as well as from lamin A overexpressed or HGPS patients show downregulated 
LAP2s (Scaffidi and Misteli 2006; Scaffidi and Misteli 2008). 
Therefore mechanisms different to retention of pRb in the nucleus could play a role in our 
experimental system. These could be the stabilizing effect of lamin A/C on pRb or the 
dephosphorylation activation, but still have to be elucidated.  
A study depleting HeLa cells for ZMPSTE24, a zinc metallopeptidase cleaving prelamin A to lamin 
A, resulted in misshaped nuclei and micronuclei formation (Gruber, Lampe et al. 2005). 
Interestingly, HU is a substance accelerating the formation of micronuclei which contain 
extrachromosomally amplified genes (Von Hoff, McGill et al. 1992). In our experimental system 
we could observe dysmorphology of the nuclei with increased micronuclei formation after HU 
treatment. The micronuclei contained the amplified MYCN copies. Moreover, prelamin A increased 
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markedly in spontaneous senescent cells. These spontaneous F-cells contain only few, down to one 
copy of MYCN per cell. We assume that prelamin A also accumulates in HU induced senescent 
cells but this has to be verified. 
As HU inhibits the active centres of zinc metalloproteinases (Campestre, Agamennone et al. 2006), 
this might be one possibility how ZMPSTE24 is inactivated. This might lead to accumulation of 
prelamin, which as a second step, might imply induction of a senescent phenotype. Papers report 
that PI inhibitors used for HIV treatment also block ZMPSTE24. Interestingly, these PI inhibitors 
induced oxidative stress in fibroblasts. This could also be seen in HU treated neuroblastoma cells. 
Another hint of possible relation between a change in nuclear lamina composition, oxidative stress 
and premature senescence is that neuroblastoma cells (SH-SY5Y) under oxidative stress were found 
to express lamin A/C (Nakamura, Yamada et al. 2006). 
Lamin A/C mutation moreover was lately not only mentioned in context with Hutchinson Gilford 
progeria, a disease of premature aging, but also with physiological aging. It was suggested that cells 
of healthy old individuals show misshaped nuclei with lamin A incorporations similar to HGPS 
cells. Moreover, in HGPS the depletion of mesenchymal stem cells should be brought about by 
incorporated lamin A into the membrane, which is thought to be a cellular marker for differentiation 
and thus halts pluripotency (Scaffidi and Misteli 2008). Here, we could show that prelamin A 
accumulated in F-cells which might be the trigger for transformation of N-cells to F-cells. By 
induction of F-cells with HU, prelamin A might also accumulate leading to the premature senescent 
phenotype seen. 
5.5 Analysis of the Senescence Pathway 
MNA neuroblastoma was correlated to high MYCN protein levels (Nakagawara, Arima et al. 1992). 
In our time course experiments high MYCN levels were shown at time point 0 but with ongoing 
treatment, the level of MYCN reduced to unverifiable amounts (Figure 33). This was also correlated 
with MYCN dmin reduction seen in the FISH experiments. Although the amount of MYCN FISH 
spots per nucleus was higher as compared to the 10 days treated cells, protein levels were lowest in 
senescent cells. Interestingly, MYCN inhibition by peptide nucleic acid leads to diminished MDM2, 
stabilized p53 and apoptosis (Slack, Chen et al. 2005). In our experimental system, we could also 
see an increase in p53 protein levels related to MYCN decrease (Figure 33). For the first time we 
show that HU induces MYCN downregulation and p53 stabilization in MNA neuroblastoma cells.  
The heterogeneity in the phenotypes after HU treatment - cells of one population undergo cell 
death, differentiation/maturation and senescence - might be the result of genetic differences 
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between treated cells. In another experimental system it was shown that p53 was needed for a HU-
induced senescence (Marusyk, Wheeler et al. 2007), but not for all cells (Hong, Hong et al. 2004). 
Here we could demonstrate that p53 is induced by HU treatment after 5 days in MNA 
neuroblastoma cells (Figure 33). p53 on the other hand, is not only involved in the senescence 
pathway, but also in apoptosis induction by involvement of ROS (Polyak, Xia et al. 1997). Thus 
differences in the level of CDKIs may discriminate between senescence, apoptosis or 
differentiation. In cultured fibroblasts it was shown that the diversity in between one senescent 
population is high as cells expressing mainly p16 were found next to cells expressing primarily p21 
(Itahana, Zou et al. 2003). Here, p21 levels peak after 5 days of HU treatment (Figure 33). This 
could be the result of increased p21 stability brought about by HU (Kim, Yeo et al. 2005) and/or by 
direct induction through its upstream effector p53. 
p16 levels, on the other hand decrease with treatment and showed a minimum at day 10 of 
treatment, while later on levels increased again slightly. p16 expression as in our untreated MNA 
cells was correlated with aggressive tumour behaviour. Moreover, most of these primary 
neuroblastoma investigated showed no functional p16-pRb pathway (Omura-Minamisawa, 
Diccianni et al. 2001). Thus, it is not surprising that pRb protein levels show only slight differences, 
despite its activity in terms of phosphorylation was not determined. Perhaps the combined function 
of p16 and p21 discriminates the different pathways but to clarify this point more experiments have 
to be carried out. A significant reduction in cell proliferation, a G1 specific cell cycle arrest and an 
extensive neuronal differentiation of neuroblastoma cells (SK-N-BE) were also shown in cells 
depleted for cyclin D and CDK4 (Molenaar, Ebus et al. 2008). 
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List of Abbreviations 
1O2 singlet oxygen 
8OHdG 8-hydroxy-2'-deoxyguanosine 
ABCC1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 
ALK anaplastic lymphoma receptor tyrosine kinase 
ALT alternative lengthening of telomeres 
APC anaphase-promoting-complex 
AT ataxia-telangiectasia 
ATM ataxia-telangiectasia mutated 
ATP adenosin triphosphate 
ATR ataxia telangiectasia and Rad3 related 
ATRIP ataxia telangiectasia and Rad3 related interacting protein 
BAF barrier to autointegration factor 
Bcl-2 B-cell CLL/lymphoma 2 
bHLH-LZ basic helix-loop-helix/leucine zipper motif 
BLM helicase bloom helicase 
BR basic DNA binding region 
BrdU bromodeoxyuridine 
BSA Bovine Serum Albumin 
CCD charge coupled device 
CD44 Phagocytic Glycoprotein-1 
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